Professor Gordon Howarth

Biography/ Background

	BSc majoring in Microbiology & Immunology (University of Adelaide 1976)
	BSc (Hons) Immunology (University of Adelaide 1977)
	PhD (University of Adelaide 2002)
	MAIMS (Australian Institute of Medical Scientists 2002)
	ARCPA (Royal College of Pathologists of Australasia 2004)
	Research Fellow (Cancer Council SA 2005-2008)
	AGAF (American Gastroenterological Association Fellow 2006)
	Associate Professor (University of Adelaide: 2006-2010)
	Professor (University of Adelaide: 2011-Present)
	Sally Birch Cancer Council Senior Research Fellow 2009-2011             SA Cancer Research Collaborative Senior Research Fellow 2012-2014

Qualifications

	BSc majoring in Microbiology and Immunology (University of Adelaide 1976)
	BSc [Hons] Immunology (University of Adelaide 1977)
	PhD (University of Adelaide 2002)

Teaching Interests

Professor Howarth is the coordinator for the Laboratory Animal Science course that was introduced in the B Sc (Animal Science) program in 2007.  Professor Howarth is a work experience student coordinator at the University and at the Women's and Children's Hospital. He also supervises groups of 3rd year Physiology students in research projects annually. Professor Howarth currently has five PhD students, one M Phil student and four Honours students in his laboratory.

Research Interests

Professor Howarth's research focuses on understanding the mechanisms by which newly-identified bioactive agents act in the intestine. These bioactive agents include probiotics, probiotic-sourced bioactives, prebiotics, synbiotics and bioactive extracts of plant, animal and marine origin. Dr Howarth has developed a wide range of animal models of gastrointestinal disease over a 20-year period. These include models of gastric ulceration, NSAID-enteropathy, chemotherapy-induced mucositis, radiation enteritis, the inflammatory bowel diseases Crohn's disease and ulcerative colitis, and colon cancer. He has utilized these models to demonstrate therapeutic applications for a number of growth factors (eg IGF-I, the subject of Professor Howarth's PhD studies) and bioactive formulations including a whey-derived growth factor extract that is currently undergoing clinical trial for the treatment of oral mucositis. Although Professor Howarth has been an Affiliate title-holder in the University for many years, he joined the University of Adelaide as an Associate Professor in the Discipline of Agricultural and Animal Science in early 2006. Professor Howarth is supported by a Senior Research Fellowship from the Cancer Council of Australia. Specific areas of research in the Howarth laboratory include:

"       Application of probiotics and probiotic-sourced factors for prevention of bowel inflammation
"       The role of medium-chain fatty acids in the development of colon cancer 
"       Effects of chemotherapy agents on intestinal stem cell expression
"       Effects of new bioactive agents on intestinal stem cell expression
"       Determining potential efficacy of prebiotics such as FOS/GOS in models of intestinal mucositis and inflammatory bowel disease 
"       Determining potential efficacy of newly-identified bioactives including dipeptidyl peptidase inhibitors, marine and land mollusc-sourced extracts, wine-sourced procyanidins and herbal extracts for treatment of intestinal mucositis, inflammatory bowel disease and other bowel disorders
"       Gut function analyses of congenital disorders such as  mucopolysaccharidosis
"       Determining gene expression profiles in the intestine
"       Nutraceutical modification of animal diets to improve growth performance and animal welfare

Publications

(a) Refereed Journal Articles

1. JD Lomax-Smith, LA Zabrowarny, GS Howarth, AE Seymour and AJ Woodroffe. The immunochemical characterization of mesangial IgA deposits. Am. J. Pathol. 113: 359-364 (1983).
Ranked first in its field. – 1/64. IF = 6.760, Citations = 78. ERA ranking = A*

2. KM Bannister, GS Howarth, AR Clarkson and AJ Woodroffe. Glomerular IgG subclass distribution in human glomerulonephritis. Clin. Nephr. 19(4): 161-165 (1983).
Rank – 25/44. IF = 1.344, Citations = 39. ERA ranking = B

3. GM Hale, GS Howarth, I Aarons, AR Clarkson and AJ Woodroffe. Quantitation of glomerular angiotensin II receptors in IgA nephropathy. Clin. Nephr. 32(1):5-9 (1989).
Rank – 25/44. IF = 1.344, Citations = 9. ERA ranking = B

4. LC Read, FM Tomas, GS Howarth, AA Martin, K Edson, PC Owens and FJ Ballard. IGF-I and its N-terminal modified analogs induce marked gut growth in dexamethasone-treated rats. J. Endocrinol. 133: 421-431 (1992).
Rank – 25/88. IF = 2.970, Citations = 91. ERA ranking = A

5. AB Lemmey, FJ Ballard, AA Martin, FM Tomas, GS Howarth and LC Read. Treatment with IGF-I peptides improves absorption of the remnant gut following small bowel resection in rats. Growth Factors 10: 243-252 (1994).
Rank – 57/156. IF = 3.742, Citations = 32.
Comment: Appeared on front cover of journal. ERA ranking = B

6. KA Ribbons, GS Howarth, KB Davey, C George-Nascimento and LC Read. Subcutaneous but not intraluminal epidermal growth factor stimulates colonic growth in normal adult rats. Growth Factors 10(3): 153-162 (1994).
Rank – 57/156. IF = 3.742, Citations = 17. ERA ranking = B

7. MA Conlon, GL Francis, FM Tomas, JC Wallace, GS Howarth and FJ Ballard. Continuous 14 day infusion of insulin-like growth factor (IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. J. Endocrinol. 144: 91-98 (1995).
Rank – 25/88. IF = 2.970, Citations = 25. ERA ranking = A

8. MA Conlon, GL Francis, FM Tomas, JC Wallace, GS Howarth and FJ Ballard. Long R3-IGF-I infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. J. Endocrinol. 146: 247-253 (1995).
Rank – 25/88. IF = 2.970, Citations = 23. ERA ranking = A

9. GS Howarth, GL Francis, JC Cool, X Xu, RW Byard and LC Read. Milk growth factors enriched from cheese whey ameliorate intestinal disease by methotrexate when administered orally to rats. J. Nutrition 126: 2519-30 (1996).
Rank – 4/50. IF = 3.771, Citations = 69. ERA ranking = A

10. GS Howarth, R Fraser, CL Frisby, MB Schirmer and EK Yeoh. Effects of insulin-like growth factor-I administration on radiation enteritis in rats. Scand. J. Gastro. 32(11): 1118-1124 (1997).
Rank – 21/45. IF = 1.847, Citations = 33. ERA ranking = B

11. KA Ribbons, GS Howarth, WDA Ford, C George-Nascimento, AJ Bourne and LC Read. Effects of epidermal growth factor administration on repair of acetic acid-induced colonic ulcerations in rats. Growth Factors 14(2-3): 89-101 (1997).
Rank – 57/156. IF = 3.742, Citations = 2. ERA ranking = B

12. GS Howarth, JC Cool, AJ Bourne, FJ Ballard and LC Read.  Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 15: 279-292 (1998).
Rank – 57/156. IF = 3.742, Citations = 49. ERA ranking = B

13. GS Howarth, CJ Xian and LC Read. Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium.  Scand. J. Gastro. 33: 180-190 (1998).
Rank – 21/45. IF = 1.847, Citations = 36. ERA ranking = B

14. SN Porter, GS Howarth and RN Butler. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats. Scand. J. Gastro. 33: 967-974 (1998).
Rank – 21/45. IF = 1.847, Citations = 7. ERA ranking = B

15. CD Tran, RN Butler, JC Philcox, AM Rofe, GS Howarth and P Coyle. Regional distribution of metallothionein and zinc in the mouse gut: Comparison with metallothionein-null mice. Biological Trace Element Research 63: 1-13 (1998).
Rank – 15/42. IF = 1.071, Citations = 17. ERA ranking = B

16. R Fraser, CL Frisby, LA Blackshaw, MB Schirmer, GS Howarth and EK Yeoh. Small intestinal dysmotility following abdominal irradiation in the isolated rat small intestine.  Neurogastroenterology and Motility 10: 413-419 (1998).
Rank – 17/45. IF = 2.083, Citations = 9. ERA ranking = B

17. CD Tran, RN Butler, GS Howarth, JC Philcox, AM Rofe and P Coyle. Regional distribution and localisation of zinc and metallothionein in the intestine of rats fed diets differing in zinc content. Scand. J. Gastro. 34: 689-695 (1999).
Rank – 21/45. IF = 1.847, Citations = 18. ERA ranking = B

18. CJ Xian, GS Howarth, CE Mardell, JC Cool, M Familari, LC Read, and AS Giraud. Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair. Am. J. Physiol. 277: G785-G795 (1999).
Rank – 8/45. IF = 3.346, Citations = 34. ERA ranking = A

19. CJ Xian, X Xu, CE Mardell, GS Howarth, RW Byard, DJ Moore, P Miettinen and LC Read. Site-specific changes in transforming growth factor and  expression in colonic mucosa of adolescents with inflammatory bowel disease. Scand. J. Gastro. 34: 591-600 (1999).
Rank – 21/45. IF = 1.847, Citations = 11. ERA ranking = B

20. CJ Xian, RT Couper, GS Howarth, CE Mardell, LC Read and NC Kallincos. Increased expression of HGF and its receptor c-met in rat small intestine during recovery from methotrexate-induced mucositis. Br. Jour. Cancer 82: 945-952 (2000).
Rank – 25/114. IF = 3.639, Citations = 24. ERA ranking = A

21. GS Howarth, CJ Xian and LC Read. Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth Factors 18: 119-133 (2000).
Rank – 49/88. IF = 1.625, Citations = 20. ERA ranking = B

22. R Fraser, CL Frisby, LA Blackshaw, J Langman, GS Howarth and EK Yeoh. Divergence of mucosal and motor effects of IGF-I and LR3IGF-I on isolated rat ileum following abdominal irradiation. J. Gastro. Hepatol. 15 (10): 1132-1137 (2000).
Rank – 25/45. IF = 1.521, Citations = 3. ERA ranking = B

23. RH Grose, GS Howarth, CJ Xian and A Hohmann. Expression of B7 costimulatory molecules by cells infiltrating the colon in experimental colitis induced by oral dextran sulphate sodium in the mouse.  J. Gastro. Hepatol. 16(11): 1228-1234 (2001).
Rank – 25/45. IF = 1.673, Citations = 8. ERA ranking = B

24. JC Clarke, RN Butler, GS Howarth, LC Read and GO Regester. Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster. Oral Oncol 38(5):478-485 (2002).
Rank – 61/114. IF = 1.873, Citations = 18. ERA ranking = B

25. CJ Xian, JC Cool, GS Howarth and LC Read. Effects of TGF gene knockout on epithelial cell proliferation, migration, apoptosis, and repair of acute damage in the small intestine. J Cell Physiol 191, 105-115 (2002).
Rank = 6/73. IF = 5.486, Citations = 16. ERA ranking = A

26. SM Garnaut, GS Howarth and LC Read. Effects of Insulin-like Growth Factor-I and its analogue, long-R3-IGF-I on Intestinal Absorption of 3-O-methyl-D-Glucose are Less Pronounced than Gut Mucosal Growth Responses. Growth Factors. 5(1):17-25 (2002).
Rank – 49/88. IF = 1.625, Citations = 2. ERA ranking = B

27. CD Tran, GS Howarth, JC Philcox, AM Rofe, P Coyle and RN Butler. Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine. Am J Clin Nutr. 77(5), 1296-1303 (2003).
Rank – 3/50. IF = 6.603, Citations = 22. ERA ranking = A*

28. BH Bajka, CM Gillespie, C-B Steeb, LC Read and GS Howarth. Applicability of the Ussing chamber technique to permeability determinations in functionally distinct regions of the gastrointestinal tract. Scand J Gastro. 38(7): 732-741 (2003).
Rank – 21/45. IF = 1.847, Citations = 14. ERA ranking = B

29. GS Howarth, SEP Bastian, AJ Dunbar and C Goddard. Betacellulin promotes growth of the gastrointestinal organs and induces a diuresis in normal rats. Growth Factors 21(2): 79-86 (2003).
Rank – 49/88. IF = 1.625, Citations = 5. ERA ranking = B

30. CJ Xian, GS Howarth, JC Cool and BK Foster. Effects of acute 5-Fluorouracil chemotherapy on IGF-I pre-treatment in growth plate cartilage and metaphyseal bone in rats. Bone 35: 739-749 (2004).
IF= 3.955, Citations = 11. ERA ranking = A

31. NS Pelton, DR Tivey, GS Howarth, GP Davidson and RN Butler. A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastro 39 (10): 1015-1016 (2004).
Rank – 21/45. IF = 1.847, Citations = 21. ERA ranking = B

32. JC Cool, JL Dyer, CJ Xian, RN Butler MS Geier and GS Howarth. Pre-treatment with insulin-like growth factor-I partially ameliorates chemotherapy-induced intestinal mucositis in the rat. Growth Hormone and IGF Research. 15 (1): 72-82 (2005). 
Rank - 32/88. IF = 2.169, Citations = 27. ERA ranking = C

33. MS Geier, D Tenikoff, R Yazbek, G McCaughan, CA Abbott, M Gorrell and GS Howarth. Development and resolution of experimental colitis in dipeptidyl peptidase IV deficient mice. J Cell Physiol. 204(2): 687-692 (2005).
Rank - 6/73. IF = 5.486, Citations = 19. ERA ranking = A

34. D Tenikoff, KM Murphy, M Le, P Howe and GS Howarth. Lyprinol (stabilised lipid extract of New Zealand Green-Lipped mussel): a potential treatment modality for inflammatory bowel disease.  J Gastroenterol. 40(4): 361-365 (2005).
Rank - 18/55. IF= 3.117. Citations = 15. ERA ranking = B

35. JM Clarke, NS Pelton, BH Bajka, GS Howarth, LC Read and RN Butler. Use of the sucrose breath test to assess chemotherapy-induced mucositis in the rat. Cancer Biol Therap. 5(1): 34-38 (2006).
Rank - 41/123. IF = 3.419. Citations = 18. ERA ranking = B

36. KL Tooley, GS Howarth, GP Davidson and RN Butler. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Therap. 5(6): 593-600 (2006).
Rank - 41/123. IF = 3.419. Citations = 23. ERA ranking = B

37. GS Howarth, KL Tooley, GP Davidson and RN Butler. A Non-Invasive Method for Detection of Intestinal Mucositis Induced by Different Classes of Chemotherapy Drugs in the Rat. Cancer Biol Therap. 5(11): 1189-1195 (2006).
Rank - 41/123. IF = 3.419. Citations = 12. ERA ranking = B
Comment:  Appeared on front cover of journal
  Commentary: Keefe DM, Gibson RJ. Cancer Biol Therap. 5(9):1196-8 (2006).

38. R Kamil, MS Geier, RN Butler and GS Howarth. Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy. Dig Dis Sci. 52(5):1247-52 (2007). 
Rank - 30/46. IF = 1.427. Citations = 9. ERA ranking = B

39. CA Mauger, RN Butler, MS Geier, KL Tooley and GS Howarth. Probiotic effects on 5-Fluorouracil-induced mucositis assessed by the sucrose breath test. Dig Dis Sci 52(3): 612-619 (2007). 
Rank - 30/46. IF = 1.427. Citations = 9. ERA ranking = B

40. CJ Xian, JC Cool, J van Gangelen, BK Foster and GS Howarth. Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats. Cancer Biol Ther.;6(2): 170-177 (2007).
Rank - 41/123. IF = 3.419. Citations = 3. ERA ranking = B

41. MS Geier, RN Butler, PM Giffard and GS Howarth. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int J Food Micro 114(3):267-274 (2007).
Rank - 4/93. IF = 2.500. Citations = 24. ERA ranking = A

42. JR Coldwell, BD Phillis, K Sutherland, GS Howarth and LA Blackshaw. Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery. J Physiol. 15;579(Pt 1):203-13 (2007).
Rank - 6/78. IF = 4.581. Citations = 27. ERA ranking = A*

43. MS Geier, RN Butler, PM Giffard and GS Howarth. Prebiotic and Synbiotic Fructooligosaccharide Administration Fails to Reduce the Severity of Experimental Colitis in Rats. Dis Colon Rectum 50: 1-9 (2007).
Rank - 18/46. IF = 2.621. Citations = 5. ERA ranking = B

44. CD Tran, JM Ball, S Sundar, P Coyle and GS Howarth. The role of zinc and metallothionein in the dextran sulphate sodium-induced colitis mouse model. Dig Dis Sci. 52:2113-2121 (2007). 
Rank - 30/46. IF = 1.427. Citations = 8. ERA ranking = B

45. GM Matthews, GS Howarth and RN Butler. Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol Ther. 6(7):1051-1057 (2007).
Rank - 41/123. IF = 2.987. Citations = 7. ERA ranking = B

46. REA Forder, GS Howarth, DR Tivey and RJ Hughes. Bacterial modulation of small intestinal goblet cells and mucin composition during early post-hatch development of poultry. Poult Sci. 86(11):2396-403 (2007).
Rank - 8/45. IF = 1.822. Citations = 8. ERA ranking = A

47. E Southcott, KL Tooley, GS Howarth, GP Davidson and RN Butler. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig Dis Sci 53(7):1837-41 (2008).
Rank - 30/46. IF = 1.427. Citations = 5. ERA ranking = B

48. REA Forder, GA Firth, DR Tivey, GS Howarth and RJ Hughes. A small-scale, low-cost isolation system for the incubation and rearing of low bacterial load chicks as a model to study microbial-intestinal interactions. Lab Animals 42(2):185-92 (2008).
IF = 0.761. Citations = 1. ERA ranking = B

49. R Yazbeck, GS Howarth, MS Geier, H-U Demuth and CA Abbott. Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice. Frontiers in Bioscience 13, 6850-6858 (2008).
IF = 2.771. Citations = 11. ERA ranking = C

50. DM Torres, KL Tooley, MS Geier, RN Butler, CL Smith and GS Howarth. Effects of Lyprinol (Lipid extract of Green-Lipped New Zealand Mussel) on chemotherapy-induced mucositis in rats. Cancer Biol Ther. 7(2):295-302 (2008).
Rank - 41/123. IF = 2.987. Citations = 6. ERA ranking = B

51. CL Smith, MS Geier, R Yazbeck, RN Butler, DM Torres and GS Howarth. Lactobacillus fermentum BR11 and Fructo-oligosaccharide Partially Reduce Jejunal Inflammation in a model of 5-FU-Induced Mucositis in Rats. Nutrition and Cancer 60(6):757-67 (2008).
Rank - 70/127. IF = 2.189. Citations = 5. ERA ranking = B

52. KL Tooley, GS Howarth, RN Butler, LC Read, KA Lymn and IA Penttila. The Effects of Formula Feeding on Physiological and Immunological Parameters in the Gut of Neonatal Rats. Dig Dis Sci 54(7):1432-9 (2009).
Rank - 23/46. IF= 1.509. Citations = 1. ERA ranking = B

53. MS Geier, CL Smith, RN Butler and GS Howarth. Small intestinal manifestations of dextran sulfate sodium consumption in rats, and assessment of the effects of Lactobacillus fermentum BR11. Dig Dis Sci. 54(6):1222-1228 (2009).
Rank - 23/46. IF= 1.509. Citations = 2. ERA ranking = B

54. KY Cheah, GS Howarth, RN Butler, C Payne, KA Lymn, R Yazbeck, TH Wright, EJ Whitford and SEP Bastian. An extract from grape seed improves parameters of small intestinal mucositis in rats with mucositis induced by 5-Fluorouracil. Cancer Biol Ther. 8(4):382-390 (2009).
Rank - 41/123. IF = 2.873. Citations = 7. ERA ranking = B
Figure used on front cover of issue.

55. AL Roberts, GS Howarth WC Liaw, S Moretta, S Kritas, KA Lymn, R Yazbeck, CD Tran, JM Fletcher, RN Butler and S Byers. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA. J Cell Physiol. 219(2):259-64 (2009).
Rank - 22/78. IF = 3.643. Citations = 1. ERA ranking = A

56. EJ Whitford, RN Butler, AG Cummins, KA Lymn, JK Fauser, R Yazbeck, A Lawrence, KY Cheah, TH Wright, KL Tooley, LD Prisciandaro and GS Howarth. Effects of Streptococcus thermophilus TH-4 in a rat model of 5-Fluorouracil induced mucositis. Cancer Biol Ther. 8(6):505-511 (2009).
Rank - 52/127. IF = 2.873. Citations = 5. ERA ranking = B

57. TH Wright, C Feinle-Bisset, AN Pilichiewicz, RN Butler, KA Lymn, R Yazbeck, KY Cheah, EJ Whitford, S Mashtoub and GS Howarth. The herbal extract, Iberogast, partially improves small intestinal integrity in rats with mucositis induced by 5-Fluorouracil. Cancer Biol Ther. 8(10):923-929 (2009).
Rank - 52/127. IF = 2.873. Citations = 3. ERA ranking = B

58. CD Tran, S Sundar and GS Howarth. Dietary zinc supplementation and methotrexate-induced small intestinal mucositis in metallothionein-knockout and wild-type mice. Cancer Biol Ther. 8(17):1662-1667 (2009).
Rank - 52/127. IF = 2.873. ERA ranking = B

59. KL Tooley, KA Lymn, GS Howarth and RN Butler. Optimization of the non-invasive 13C-Sucrose Breath Test in a rat model of methotrexate-induced mucositis. Cancer Chemo Pharmacol.  65(5):913-21 (2010).
Rank - 69/141. IF = 2.740. Citations = 1. ERA ranking = B

60. RJ Lindsay, MS Geier, RN Butler, KA Lymn, R Yazbeck and GS Howarth. Oral administration of emu oil decreases acute inflammation and improves selected parameters of small intestinal integrity in a rat model of mucositis. Br J Nutr.  104(4):513-9 (2010).
Rank - 11/66. IF= 3.446. ERA ranking = A

61. R Yazbeck, ML Sulda, GS Howarth, A Bleich, K Raber, S von Horsten, JJ Holst and CA Abbott. Dipeptidyl Peptidase expression during experimental colitis in mice. Inflamm Bowel Dis. 16(8):1340-51 (2010). Citations = 1.
Rank - 10/55. IF = 4.975. ERA ranking = A

62. RP Miegel, SJ Pain, WHEJ Van Wettere, GS Howarth and DJA Stone. Effect of water temperature on gut transit time, digestive enzyme activity and nutrient digestibility in yellowtail kingfish (Seriola lalandi). Aquaculture 308: 145-151 (2010).
Rank - 9/40. IF = 1.678. ERA ranking = A

63. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Probiotic factors partially improve parameters of 5-Fluorouracil induced mucositis in rats. Cancer Biol Therap: 11(7):671-677 (2011).
Rank - 74/185. IF = 2. 907. ERA ranking = B

64. R Yazbeck, GS Howarth, RN Butler, MS Geier and CA Abbott. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.  J Cell Physiol: 226(12):3219-3224 (2011).
Rank - 22/78. IF = 3.643. ERA ranking = B

65. R Yazbeck, GS Howarth, L Borges, MS Geier, CL Smith, GP Davidson and RN Butler. Non-invasive detection of a Palifermin mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats.  Cancer Biol Therap: 12(5):399-406 (2011).
Rank - 74/185. IF = 2. 907. ERA ranking = B

66. KL Tooley, GS Howarth, KA Lymn, A Lawrence and RN Butler. Oral ingestion of Streptococcus thermophilus TH-4 does not affect tumour or mucositis progression in a tumour-bearing model of mucositis. Cancer Biol Therap: 12(2):131-138 (2011).
Rank - 74/185. IF = 2.907. ERA ranking = B

67. SM Abimosleh, RJ Lindsay, RN Butler, AG Cummins and GS Howarth. Emu Oil Increases Crypt Depth in a Rat Model of Colitis. Dig Dis Sci. 57(4):887-96 (2012).
Rank - 34/66. IF= 2.064. ERA ranking = B

68. HL Atkins, MS Geier, LD Prisciandaro, AK Pattanaik, REA Forder, MS Turner and GS Howarth. Effects of a Lactobacillus fermentum BR11 mutant deficient in the cystine transport system in a rat model of inflammatory bowel disease. Dig Dis Sci. 57 (3): 713-719 (2012).
Rank - 34/66. IF= 2.064. ERA ranking = B

69. JK Fauser, RP Donato, JA Woenig, SJ Proctor, AP Trotta, PK Grover, GS Howarth, IA Penttila and AG Cummins. Wnt blockade with dickkopf reduces intestinal crypt fission and intestinal growth in infant rats. J Ped Gastroenterol Nutr. 55(1):26-31 (2012).
Rank - 37/71. IF = 2.180. ERA ranking = B

70. AK Samanta, VA Torok, NJ Percy, SM Abimosleh and GS Howarth. Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis. J Applied Micro. 50(2):218-25 (2012).
Rank - 58/95. IF = 2.098. ERA ranking = B

71. GM Matthews, GS Howarth and RN Butler. Short-chain fatty acids induce apoptosis in colon cancer cells associated with cell cycle arrest and changes to intracellular redox state and glucose metabolism. Chemotherapy 58(2):102-109 (2012).
Rank – 112/185. IF = 2.180. ERA ranking = B

72. LD Prisciandaro, MS Geier, AE Chua, RN Butler, AG Cummins, GR Sander and GS Howarth. Probiotic factors partially prevent changes to caspase 3 and 7 activation and trans-epithelial electrical resistance in an in vitro model of 5-Fluorouracil-induced epithelial cell damage. Supp. Care Cancer. 20(12): 3205-3210 (2012).
Rank – 115/185. IF = 2.058. ERA ranking = B

73. RR Nadhanan, SM Abimosleh, Y-W Su, MA Scherer, GS Howarth and CJ Xian. Dietary emu oil supplementation suppresses 5-Fluorouracil chemotherapy-induced inflammation, osteoclast formation and bone loss. Am J Phys Endocrinol Metab. 302(11): E1440-1449 (2012).
Rank - 8/66. IF = 4.301. ERA ranking = A

74. R Terry, WHEJ Van Wettere, AL Whittaker, PJ Herde and GS Howarth. A proof of concept study in swine to investigate the feasibility of intestinal sucrase activity measurement utilizing the non-invasive 13C-sucrose breath test. Comp Med. In Press (2012).
Rank - 46/145. IF = 1.205. ERA ranking = B

75. CJ Jenvey, C Caraguel, GS Howarth and CB Riley. Identification of periparturient mare-associated and foal-associated predictors of passively acquired immunoglobulin A concentrations in Thoroughbred foals. Equine Vet J. In Press (2012).
Rank - 34/143. IF = 1.456. ERA ranking = B

76. AG Cummins, JA Woenig, RP Donato, SJ Proctor, GS Howarth and PK Grover. Notch signalling promotes intestinal crypt fission in the infant rat. Dig Dis Sci. In Press (2012).
Rank - 34/66. IF= 2.064. ERA ranking = B

77. KY Cheah, TMJ Acott, SEP Bastian, SM Abimosleh, KA Lymn and GS Howarth. Grape Seed Extract reduces the severity of selected disease markers in the proximal colon of Dextran Sulphate Sodium-induced colitis in rats. Dig Dis Sci. In Press (2012).
Rank - 37/66. IF= 1.838. ERA ranking = B

78. SM Abimosleh, CD Tran and GS Howarth. Emu Oil Expedites Small Intestinal Repair Following 5-Fluorouracil-Induced Mucositis in Rats. Exp Biol Med. In Press (2013).
 IF= 2.56. ERA ranking = B

Submitted (under review)
79. KY Cheah, GS Howarth and SEP Bastian. Dose-response effects of Grape Seed Extract in a rat model of intestinal mucositis. (Submitted to Br J Nut).
Rank - 11/66. IF= 3.446.

80. KY Cheah, GS Howarth, JA Kennedy, KA Bindon and SEP Bastian. Grape-derived proanthocyanidin fractions and effects on colon cancer cells. (Submitted to Mol Nutr Food Res).
 IF = 4.7.

In Preparation
81. JK Fauser, RN Butler, AG Cummins, GM Matthews and GS Howarth. Medium-chain fatty acid induction of cell death in the Caco-2 and IEC-6 cell lines. (To be submitted to Cancer Biol Therap).
Rank - 52/127. IF = 2.818.

82. S Mashtoub, RN Butler and GS Howarth. Emu Oil effects on intestinal repair. (To be submitted to J Nutrition).

83. RJ Lindsay, MS Geier, RN Butler and GS Howarth. Novel prebiotics and effects on intestinal mucositis in rats. (To be submitted to Dis Colon Rectum).

84. RJ Lindsay, GS Howarth, CA Abbott and K Benkendorff. Effects of a novel marine mollusc extract on chemotherapy-induced mucositis in rats. (To be submitted to J Nutrition).

85. B Hoang, R Yazbeck, M Vu, RN Butler, C Feinle-Bisset, N McWilliams and GS Howarth. Effects of a Traditional Chinese Medicine formulation and the herbal extract, Iberogast, on experimental inflammatory bowel disease. (To be submitted to J Nutrition).

 

(b) Reviews (including invited)

1. SN Porter, GS Howarth and RN Butler. Non-steroidal anti-inflammatory drugs and apoptosis in the gastrointestinal tract: potential role of the pentose phosphate pathways.  Eur J Pharmacol. 26: 397(1):1-9 (2000).
  Rank - 51/188. IF = 2.342. Citations = 12. ERA ranking = B

2. GS Howarth and CA Shoubridge. Enhancement of intestinal growth and repair by growth factors. (Invited Review). Current Opinion in Pharmacology 1(6): 568-574 (2001). Part of Current Opinion series.
  Rank - 11/205. IF = 6.309. Citations = 6. ERA ranking = A

3. GS Howarth. IGF-I and the gut: Therapeutic Indications and Safety Implications.  (Invited Review). J Nutrition 133:2109-2112 (2003).
 Rank – 4/50. IF = 3.620. Citations = 24. ERA ranking = A

4. GM Matthews, GS Howarth and RN Butler. Nutrient and antioxidant modulation of apoptosis in gastric and colon cancer cells. Cancer Biol Therap 5(6): 569-572 (2006).
 Rank - 41/123. IF = 3.419. Citations = 5. ERA ranking = B

5. MS Geier, RN Butler and GS Howarth. Probiotics, prebiotics and synbiotics: a role for chemoprevention in colorectal cancer ?. Cancer Biol Ther. 5(10): 1265-1269 (2006).
Rank - 41/123. IF = 3.419. Citations = 31. ERA ranking = B

6. MS Geier, RN Butler and GS Howarth. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol. 115(1):1-11 (2007).
Rank - 4/96. IF = 2.608. Citations = 37. ERA ranking = A

7. LD Prisciandaro, MS Geier and GS Howarth. Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflamm Bowel Dis 15(12):1906-1914 (2009).
Rank - 10/55. IF = 4.975. Citations = 5. ERA ranking = A

8. KL Tooley, GS Howarth and RN Butler. Mucositis and non-invasive markers of small intestinal function. Cancer Biol Ther. 8(9):753-758 (2009).
Rank - 52/127. IF = 2.873. Citations = 3. ERA ranking = B

9. R Yazbeck, GS Howarth and CA Abbott. Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?. Cytokine Growth Factor Reviews. 20(2):175-184 (2009).
Rank – 12/156. IF = 11.816. Citations = 11. ERA ranking = A

10. R Yazbeck, GS Howarth and CA Abbott. Dipeptidyl peptidase-IV inhibitors: an emerging drug class for inflammatory disease. Trends in Pharmacological Science. 30(11): 600-607 (2009).
Rank – 4/205. IF = 9.610. Citations = 15. ERA ranking = A

11. R Yazbeck, CA Abbott and GS Howarth. The use of glucagon-like factor-2 (GLP-2) and related growth factors in intestinal diseases. Current Opinion in Investigational Drugs. 11(4):440-6. (2010).
Rank – 57/219. IF = 3.324. Citations = 3. ERA ranking = C

12. LD Prisciandaro, MS Geier and GS Howarth. Evidence supporting the use of probiotics in the prevention and treatment of chemotherapy-induced mucositis. Crit Rev Food Sci Nutr. 51(3):239-47 (2011).
Rank - 5/55. IF = 4.154. ERA ranking = A

13. JK Fauser, LD Prisciandaro, AG Cummins and GS Howarth. Fatty acids as potential adjunctive colorectal chemotherapeutic agents. Cancer Biol Therap. 11(10): 724-731 (2011).
Rank - 74/185. IF = 2. 907. ERA ranking = B

14. SM Abimosleh, CD Tran and GS Howarth. Emu Oil: a novel treatment approach for disorders of the alimentary system. J Gastro Hepatol. 27(5):857-61 (2012).
Rank - 29/55. IF = 2.275. ERA ranking = B

15. H Wang, MS Geier and GS Howarth. Prebiotics: a potential treatment strategy for the chemotherapy-damaged gut?. Crit Rev Food Sci Nutr. In Press (2013).
Rank - 5/55. IF = 4.154. ERA ranking = A

16. GS Howarth and H Wang. Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5(1): 58-81 (2012).

 

Submitted (under review)
17. KY Cheah, GS Howarth and SEP Bastian. Grape seed proanthocyanidins and intestinal health: bioavailability, mechanism of action and safety dosage. J. Ethnopharmacol (2011).
Rank - 119/236. IF = 2.322.

(c) Books – None as yet.

(d) Book Chapters/Published Conference Proceedings

1. LC Read, AB Lemmey, GS Howarth, AA Martin, FM Tomas and FJ Ballard. The gastrointestinal tract is one of the most responsive target tissues for IGF-1 and its potent analogs. p225-234. In: Modern Concepts of Insulin-like growth factors. Ed. E. Martin Spencer. Elsevier Science Publishing Company Inc. (1991).

2. LC Read, GS Howarth, AB Lemmey, C-B Steeb, J Trahair, FM Tomas and FJ Ballard. The gastrointestinal tract: a most sensitive target for IGF-I. Proc. NZ Nutrition Soc. 17: 136-142 (1992).

3. LC Read, GS Howarth, C-B Steeb and AB Lemmey. In vivo effects of IGF-I on gut growth and function. In : The insulin-like growth factors and their regulatory proteins.  Proceedings of the Third International Symposium on Insulin-like Growth Factors p409-416. Ed. R.C Baxter, P.D. Gluckman and R.G. Rosenfeld. Elsevier Science Publishing Company Inc. (1994).

4. GO Regester, DA Belford, C Goddard, GS Howarth, GS Smithers, AC Copeland, KS De Silva, LS Toneman and LC Read. Prospective clinical applications for a growth factor extract from whey: gut disease and wound repair. Proc International Whey Conference. (1997).

5. LC Read, GS Howarth, JC Cool, C-B Steeb, AB Lemmey and K Penning. IGFs and gut disease. Proc. Second DSL International Conference p166-170, (1997).

6. C-B Steeb, CA Shoubridge, J Lamb, GS Howarth and LC Read. Role of insulin-like growth factor-I (IGF-I) in gastrointestinal growth and repair. In: Molecular mechanisms to regulate the activities of insulin-like growth factors.  Proceedings of the Fourth International Symposium on Insulin-like Growth Factors.  Elsevier Science Publishing Company Inc. p. 331-339 (1998).

7. GS Howarth, SEP Bastian, AJ Dunbar, NC Kallincos and C Goddard. The terminal ileum of the rat is responsive to betacellulin administration. Digestive and Liver Disease [Proceedings of International meeting on Inflammatory Bowel Diseases – Capri, Italy (2000)].

8. GS Howarth, RH Grose, CJ Xian and A Hohmann. Expression of B7 costimulatory molecules in experimental IBD. Digestive and Liver Diseases [Proceedings of International meeting on Inflammatory Bowel Diseases – Capri, Italy (2000)].

9. LC Read, IA Penttila, GS Howarth, JM Clarke and GO Regester. Role and function of growth factors in infant nutrition. Infant Formulae: Closer to the Reference.  Ed. NCR Raiha and FF Rubaltelli.  Nestlé Nutrition Workshop Series.  Paediatric Program. Volume 47 Supplement : 185-196 (2000).

10. SM Brierley, JR Coldwell, NJ Cooper, GS Howarth and LA Blackshaw. Colonic apical primary afferents mechanosensory and chemosensory subtypes and effects of inflammation. Proceedings of Falk Symposium. GI Inflammation and Disturbed Gut Function: The Challenge of New Concepts. Freiburg Germany (2002).

11. D Tenikoff, KJ Murphy, M Le, RN Butler, PR Howe and GS Howarth. Lyprinol(tm): a potential preventive treatment for inflammatory bowel disease (IBD)? Asia Pac J Clin Nutr. Aug;13(Suppl):S94 (2004).

12. CA Abbott, R Yazbeck, MS Geier, H-U Demuth and GS Howarth. Dipeptidyl peptidases and inflammatory bowel disease. Dipeptidyl Aminopeptidases Basic Science and Clinical Applications Series: Advances in Experimental Medicine and Biology, Vol. 575, 155-162 (2006).

13. GS Howarth. Probiotics and Inflammatory Bowel Disease. (Falk Inflammatory Bowel Disease Symposium No. 151. Emerging Issues in Inflammatory Bowel Diseases, p281-295 (2006).

14. REA Forder, C Masselott-Robbe, GS Howarth, DR Tivey and RJ Hughes. The influence of bacterial exposure on intestinal mucin composition and structure during post-hatch development of poultry. Aust J Exp Agric 48(12): 1272-1278 (2008).

15. GS Howarth, RJ Lindsay, RN Butler and MS Geier. Can emu oil ameliorate inflammatory disorders affecting the gastrointestinal system?. Aust J Exp Agric 48 (12): 1276-1279 (2008).

16. GS Howarth. Inflammatory Bowel Disease (IBD), a Dysregulated Host-Microbiota interaction: Probiotics and Prebiotics, a new therapeutic option?. Proceedings of Fifth International Symposium on Probiotics: 58-66 (2008).

17. GS Howarth. New advances in animal feed nutrition with probiotics and prebiotics. Probiotech International Symposium on Prebiotics: 93-102 (2009).

18. LD Prisciandaro, GS Howarth and MS Geier. Probiotics and Prebiotics in Inflammatory Bowel Disease?. In: Handbook of Prebiotics and Probiotics Ingredients: Health Benefits and Food Applications. Chapter 12: p233-258. CRC Press – Taylor and Francis Group (2009).

19. CJ Xian, CM Fam, JC Cool, MA Scherer, T King, KR Georgiou, RR Nadhanan, GS Howarth, T Shandala, BK Foster. Pathobiology and prevention of bone growth defects caused by cancer chemotherapy. International Journal of Molecular Medicine 24(1): S24-S24 (2009).

20. B Konsak, T Crowley, D Stanley, V Haring, RJ Hughes, GS Howarth and R Moore. Understanding the Transition from the Naive Gut to the Functionally Mature Gut in chickens. Proceedings of XIII European Poultry Conference, Tours, France (2010).

21. GS Howarth, RN Butler, S Salminen, GR Gibson and SM Donovan. Probiotics for optimal nutrition: from efficacy to guidelines. Proceedings of Experimental Biology 2012, San Diego, CA, USA. Adv Nutr 3: 720-722 (2012).

(e) Other publications

Editorials and Commentaries
1. GS Howarth. Therapeutic guidelines: Gastrointestinal, Version 4 (2006) Gastrointestinal Expert Group. Therapeutic Guidelines Limited, Melbourne, 2006. ISBN 10: 0-9757393-5-2. Commentary: Australasian Journal on Ageing, Vol 26(4):206–208 (2007). IF = 0.319. ERA ranking = B
2. GS Howarth. Inflammatory Bowel Disease (IBD), a Dysregulated Host-Microbiota Interaction: Are Probiotics a new Therapeutic Option?. Editorial: Journal of Gastroenterology and Hepatology 23(12):1777-9 (2008). Rank - 29/55. IF = 2.275. Citations = 1. ERA ranking = B
3. R Yazbeck and GS Howarth.  Complementary Medicines – Emerging Therapies for Intestinal Mucositis. Commentary: Cancer Biology and Therapy 8(17):1629-1631 (2009). Rank - 52/127. IF = 2.873. ERA ranking = B
4. GS Howarth. Probiotic-derived factors: probiotaceuticals?. Commentary: Journal of Nutrition. 140(2):229-30 (2010). Rank - 8/66. IF = 4.301. ERA ranking = A
5. GS Howarth. Prebiotic utility in colitis: will inflammasomics hold the key?. Commentary: Journal of Nutrition. 142 (7):1189-1190 (2012). Rank - 8/66. IF = 4.301. ERA ranking = A

Peer reviewed publications from other Disciplines
In addition to my primary biomedical research focus, I also contribute to peer-reviewed publications from other disciplines, including aspects of fauna and ethical research.
1. AL Whittaker, GS Howarth and DL Hickman. Effects of space allocation and housing density on measures of well-being in laboratory mice: a review. Lab Anim 46(1): 3-13 (2012).
Rank - 42/145. IF = 1.282. Citations = 1. ERA ranking = B
In Preparation
2. K Hulsman, B Edgar and GS Howarth. Environmental Ethical Issues arising from Trans-species Gene Transfer. To be submitted to Science as Culture (2013).
3. RJ Bosworth, GS Howarth and P Stott. The impact of drought on the Tammar Wallaby (Macropus eugenii), from Kangaroo Island, South Australia, assessed using a body condition score. To be submitted to Wildlife Research (2013).

Non-peer reviewed publications
Transcripts of my published work have been used for promotional purposes by the printed media on a number of occasions.  For example, my presentation at the 2002 Gastroenterological Society of Australasia in Adelaide attracted radio and printed media publicity with publication [“Dairy whey’s healing potential”] in several national newspapers in addition to the February 2003 R&D Newsletter of the Dairy Research and Development Corporation (DRDC), the “Stock and Land” periodical and the “Taste of Victoria” magazine.
• Learning about Coeliacs. The Billboard. April edition (1993)
• Dairy whey’s healing potential. Dairy R&D News. Jan/Feb (2003)
• Mouth wash leads the whey. Taste of Victoria. 5(24): 8 (2003)
• Mouth wash made with whey offers treatment for ulcerations. Cheese Market News (Weekly newspaper of the National Cheese and Dairy Deli Business). March 28 (2003)
• Research and the Cancer Council. Mosaic Cancer Support Newsletter, October (2005)
• Treatment hope for chemo side-effects. The Port Pirie Recorder. October 20th (2005)
• Research may combat side-effects of cancer treatment. Cancer Council SA Newsletter. Progress (7): Summer. (2005)
• Whey to go, Milk. The Adelaide Advertiser. July 15th (2006)
• Microscopic allies. The Adelaide Advertiser. August 19th (2006)
• Mouth ulcer discovery in SA. The Adelaide Advertiser. October 9th (2006)
• Cancer breakthrough from shellfish discovery. The Adelaidean 16(1): 5 March edition (2007)
• Ancient cures. The Adelaide Advertiser. August 11th (2007)
• Nature joins fight against side-effects of cancer treatment. Cancer Council SA Newsletter. Progress (17): Autumn (2008)
• Profile: Gordon Howarth. Cancer Council SA Newsletter. Progress (17): June (2008)
• Natural remedies. How protecting our wildlife may safeguard our own future. The Adelaide Advertiser. July 12th (2008)
• Member Profile. Healthy Development Adelaide 4(4): 2 (2008)
• Antidote found in the Anecdote. Women’s and Children’s Hospital News Periodical. Healthy Focus (14): Spring 2008
• Probiotics throughout Development. Healthy Development Adelaide 4(6): (2008)
• The Dirty End of Science. Messenger News Review. Wednesday, December 10th Edition (2008)
• Unique world of bugs. Insects provide new source of medicinals. The Adelaide Advertiser. May 19th (2009)
• Easier pills to swallow. The Australian. October 30th (2009)
• Easier pills to swallow. The Adelaide Advertiser. October 31st (2009)
• Easier pills to swallow. The Adelaidean. 18(9): 20 (November 2009)
• Natural therapies: Clinical recognition. The Adelaide Advertiser. November 10th (2009)
• NZ mussel extract can ease chemo effects. Daily New Zealand News. November 10th (2009)
• NZ mussel extract can mitigate chemo effects: Study. Wellington Voxy News. November 10th (2009)
• Healthy Development Adelaide School Education Program. Healthy Nutrition (Roxby Downs visit). Healthy Development Adelaide 6(3): (2010)
• Probiotics and bowel disease: which ones?, how many? and how often?. Gate2Tech News 1(0): (2011)
• Faculty of Sciences E-Magazine. SM Abimosleh and GS Howarth. Emu Oil: a role for natural medicines in the fight against gastrointestinal disease. Edition 1 (2012)
• Good oil on emus (with S Abimosleh). The Adelaide Advertiser. June 27th (2012)
• ‘Babies and Bugs: What’s going on in the gut’. Healthy Development Adelaide 8(4): (2012)
• Bugs we would love to have a gutful of (with W Wang). The Adelaide Advertiser. October 9th (2012)

Government Reports
While a member of the Office of the Gene Technology Regulator (OGTR) Gene Technology Ethics Committee (GTEC) and Gene Technology Technical Advisory Committee (GTTAC), I was a member of working groups producing papers on:
• Ethical Issues Arising from Trans-species Gene Transfer Submitted for publication in ‘Society as Culture’ journal
• NHMRC Australian Code for Conducting Research (2004)
• Gene Technology Act 2005 [Review panel 13th December 2005, Melbourne]
• Gene Technology Regulations 2005
• National Framework for Development of Ethical Principles in Gene Technology 2006
• Environmental Ethics and Gene Technology (2007)

Industry Reports
I have prepared a number of reports for industry collaborators and granting bodies. Some of these reports have been of considerable length (up to 100 pages) and detail, sometimes involving scientific content equivalent to a full peer-reviewed publication.
1. GS Howarth and LC Read. Whey extract and other milk-derived formulations for treatment of IBD. Nutricia Inc 1998.
2. IA Penttila, GS Howarth and LC Read. Milk-derived formulations for treatment of gut immaturity. Nestle Inc 2001.
3. GS Howarth, GW Dandie, GO Regester and LC Read. Milk-derived formulations for treatment of gastric ulceration. Bio Innovation Fund 2003.
4. GS Howarth and RN Butler. Development of the sucrose breath test. (Animal Study) Bio Innovation Fund 2004 (40 page report).
5. RN Butler, GS Howarth, GP Davidson and RN Butler. Application of the sucrose breath test to adults and children with intestinal mucositis. Bio Innovation Fund 2005 (35 page report).
6. RN Butler and GS Howarth. Applicability of the sucrose breath test to Palifermin treatment of mucositis. Amgen Pty. Ltd. (2008).
7. MS Geier, GS Howarth, C Smyl and RJ Hughes. Determinations of intestinal function in poultry. Final Report for Poultry CRC. (2008).
8. GS Howarth and RN Butler. Effects of bio-active Emu Oil on chemotherapy-induced mucositis. Rural Industries Research and Development Corporation. RIRDC Publication #09/131 (2009).
9. GS Howarth. Effects of Nucleoforce F 0328 on the sucrose breath test in a rat model of mucositis. Bioiberica/Nidor Ptl Ltd collaboration (2009).
10. GS Howarth. Effects of Nucleoforce F 0328 on the small intestinal architecture and inflammation in a rat model of mucositis. Further analysis of tissue samples. Bioiberica/Nidor Ptl Ltd collaboration (2010).

(f) Published Conference Abstracts
1. GS Howarth, LA Zabrowarny and AJ Thompson. Immunofluorescent diagnosis of renal injury. Oral presentation, 7th International Workshop on Immunofluorescence and Defined Immunoenzyme Techniques, Niagara Falls, New York, USA (1982).

2. KM Bannister, GS Howarth, AR Clarkson and AJ Woodroffe. Glomerular IgG subclass distribution in human glomerulonephritis. Poster presentation Second Asian-Pacific Congress of Nephrology, Melbourne, Victoria, Australia (1983).

3. GM Hale, GS Howarth, I Aarons, AR Clarkson and AJ Woodroffe. Quantitation of glomerular angiotensin II receptors in IgA nephropathy. Poster presentation Australasian Society of Nephrology, Sydney, New South Wales, Australia (1988).

4. LC Read, FM Tomas, GS Howarth, AA Martin, K Edson, PC Owens and FJ Ballard. IGF-I and its N-terminal modified analogs induce marked gut growth in dexamethasone-treated rats. Poster presentation Gastroenterological Society of Australia, Adelaide, South Australia (1991).

5. GS Howarth, KA Penning, JC Cool and LC Read. IGF-I and repair of the methotrexate-damaged small intestine. Growth Regulation 4(1): 124 (Abst. II 296) (1994). Poster presentation, International GH and IGF Research Society, Sydney, Australia. Feb 1994.

6. GS Howarth, JC Cool, KA Penning, C-B Steeb, AB Lemmey and LC Read. Growth factors as agents of protection and repair in paediatric gut disease. J. Paediatr. Child Health. 31, A5  (1995). Poster presentation, Paediatric Research Society of Australasia, Adelaide, SA, June 1995.

7. GS Howarth, KA Penning, JC Cool, A Mercorella, LM Srpek and LC Read. Insulin-like growth factors reduce colonic damage in experimental colitis J. Gastro. Hepatol. 10 (2): A44 (1995). Oral presentation, Australian Gastroenterology Week, Perth, WA, October 1995.

8. RN Butler, CD Tran, GS Howarth and P Zalewski. Labile zinc in the rat small intestine after damage with methotrexate. J. Gastro. Hepatol. 10 (2): A47 (1995). Poster presentation, Australian Gastroenterology Week, Perth, WA, October 1995.

9. R Fraser, CL Frisby, MB Schirmer, EK Yeoh and GS Howarth. Effects of insulin-like growth factor-I administration on mucosal response to radiation induced injury. Gastroenterology 110(4): A1072 (1996). Poster presentation, Digestive Diseases Week, San Francisco, USA. May 1996.

10. GS Howarth, KA Penning, D Antoniou, A Mercorella, LM Srpek, and LC Read. J. Gastro. Hepatol. 11: A102 (1996). Insulin-like growth factors reduce colonic damage in a rat model of inflammatory bowel disease induced by oral dextran sulphate sodium. Oral presentation, Australian Gastroenterology Week, Adelaide, SA, October 1996.

11. SM Garnaut, GS Howarth and LC Read. Intestinal absorption of 3-methyl-glucose in rats treated with IGF-I like peptides. J. Gastro. Hepatol. 11: A103 (1996). Poster presentation, Australian Gastroenterology Week, Adelaide, SA, October 1996.

12. CD Tran, RN Butler, GS Howarth, P Coyle, JC Philcox and AM Rofe. Gut metallothionein levels in the rat in response to normal and low dietary zinc and fasting. J. Gastro. Hepatol. 11: A95 (1996). Poster presentation, Australian Gastroenterology Week, Adelaide, SA, Oct 1996.

13. GS Howarth and LC Read. Insulin-like growth factors reduce colonic damage in a rat model of inflammatory bowel disease induced by oral dextran sulphate sodium. Gastroenterology 110(4): A927 (1996). Oral presentation, Digestive Diseases Week, San Francisco, USA. May 1996.

14. R Fraser, CL Frisby, MB Schirmer, EK Yeoh and GS Howarth. IGF-I and mucosal response to radiation injury. J. Gastro. Hepatol. 11: A98 (1996). Oral presentation, Australian Gastroenterology Week, Adelaide, SA, October 1996.

15. SN Porter, GS Howarth and RN Butler. WGFE decreases an indicator of colitic disease activity in the DSS model of colitis. Gastroenterology 112(4): A1063 (1997). Poster presentation, Digestive Diseases Week, Washington, USA. May 1997.

16. CJ Xian, GS Howarth, C Mardell and LC Read. Expression of TGF-alpha and beta1 in rat colonic mucosa with DSS-induced acute and chronic colitis and dysplasia. J. Gastro. Hepatol. 12: A57 (1997). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 1997.

17. GS Howarth and LC Read. Insulin-like growth factor-I does not increase the incidence of dysplasia in a rat model of chronic IBD. Gastroenterology 112(4): A580 (1997). Poster presentation, Digestive Diseases Week, Washington, USA. May 1997.

18. C Frisby, EK Yeoh, M Schirmer, GS Howarth and R Fraser. Abdominal irradiation results in small intestinal dysmotility in the isolated rat small intestine. J. Gastro. Hepatol. 12: A15 (1997). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 1997.

19. CD Tran, RN Butler, P Coyle, J Philcox, AM Rofe and GS Howarth. Metallothionein regulation of intestinal zinc. J. Gastro. Hepatol. 12: A88 (1997). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 1997.

20. CJ Xian, C Mardell, GS Howarth and LC Read. IGF-I treatment reduces colonic inflammation in the rat model of DSS-colitis. Gastroenterology 112(4): A1122 (1997). Poster presentation, Digestive Diseases Week, Washington, USA. May 1997.

21. SN Porter, GS Howarth and RN Butler. Whey-derived growth factor extract suppresses an indicator of disease activity in the dextran sulphate sodium model of colitis.  J. Gastro. Hepatol. 12: A15 (1997). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 1997.

22. CD Tran, GS Howarth, RN Butler, P Coyle, J Philcox and AM Rofe. Metallothionein and zinc in methotrexate-induced damage in rats. J. Gastro. Hepatol. 12: A87 (1997). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 1997.

23. GS Howarth, R Fraser, C Frisby, M Schirmer and E Yeoh. Insulin-like growth factor-I and Long R3-IGF-I are equipotent at stimulating intestinal regrowth following experimental radiation enteritis in rats. Gastroenterology 114(4, Pt. 2): A154 (1998). Poster presentation, Digestive Diseases Week, New Orleans, USA. May 1998.

24. CJ Xian, GS Howarth, C Mardell and LC Read. Effects of long-term infusion of IGF-I on colonic cell proliferation in rats with chronic colitis.  Gastroenterology 114(4, Pt. 2): A706 (1998). Poster presentation, Digestive Diseases Week, New Orleans, USA. May 1998.

25. CJ Xian, C Mardell, GS Howarth, JC Cool, D Tran, RT Couper, LC Read and NC Kallincos. Increased expression of HGF and its receptor c-met in rat small intestine during recovery from methotrexate-induced mucositis. J. Gastro. Hepatol. 13: A157 (1998). Poster presentation, Australian Gastroenterology Week, Canberra, ACT. October 1998.

26. CD Tran, GS Howarth, P Coyle, JC Philcox, AM Rofe and RN Butler. Zinc supplementation improves intestinal permeability in methotrexate-treated rats. J. Gastro. Hepatol. 13: A207 (1998). Poster presentation, Australian Gastroenterology Week, Canberra, ACT. October 1998.

27. CD Tran, RN Butler and GS Howarth. Zinc in combination with a growth factor extract from bovine whey promotes recovery from methotrexate-induced small bowel damage in rats. Gastroenterology 116(4, Pt. 2): G4089 (1999). Poster presentation, Digestive Diseases Week, Orlando, USA. May 1999.

28. GS Howarth, RH Grose, CJ Xian and A Hohmann. Expression of B7 costimulatory molecules by cells infiltrating the colon in dextran sulphate sodium (DSS)-induced colitis in mice. Gastroenterology 116(4, Pt. 2): G3211 (1999). Poster presentation, Digestive Diseases Week, Orlando, USA. May 1999.

29. GS Howarth, SEP Bastian, AJ Dunbar, NC Kallincos and C Goddard. Systemic administration of betacellulin to rats promotes growth of the gastrointestinal organs. Gastroenterology 118(4): 2930 (2000). Poster presentation, Digestive Diseases Week, San Diego, USA. May 2000.

30. E Southcott, NS Pelton, CD Tran, GS Howarth, GP Davidson and RN Butler. Probiotics promote region-specific recovery from methotrexate-induced small bowel damage in rats. J. Gastro. Hepatol. 16 (Supplement): A21 (2001). Poster presentation, Asia-Pacific Digestive Week, Sydney, NSW. October 2001.

31. JM Clarke, LC Read, GS Howarth, KA Ramsden, BH Bajka and RN Butler. In vivo assessment of small intestinal function by sucrose breath test in a rat model of chemotherapy-induced mucositis. Gastroenterology 122(4) (Supplement): T881 (2002). Poster presentation, Digestive Diseases Week, San Francisco, USA. May 2002.

32. GS Howarth, JM Clarke, LC Read, RN Butler, GW Dandie and IA Penttila.  Physiological, histological and immunological characterization of a rat model of prematurity.. Gastroenterology 122(4) (Supplement): T1326 (2002). Poster presentation, Digestive Diseases Week, San Francisco, USA. May 2002.

33. GS Howarth, JM Clarke, LC Read, KA Ramsden, BH Bajka and RN Butler. In vivo assessment of small intestinal function by sucrose breath test in chemotherapy-treated rats. J. Gastro. Hepatol. 17 A181 (2002). Poster presentation, Australian Gastroenterology Week, Adelaide, SA. October 2002.

34. GS Howarth, JM Clarke, LC Read, RN Butler, GW Dandie and IA Penttila.  Characterization of a rat model of gastrointestinal immaturity and artificial feeding.  J. Gastro. Hepatol. 17: A170 (2002). Poster presentation, Australian Gastroenterology Week, Adelaide, SA. October 2002.

35. JC Cool, CL Seymour-Griffin, MS Geier, D Tenikoff, S-S Lee, Y-P Dang, GW Dandie and GS Howarth. Temporal profile of repair and proliferation during recovery from indomethacin injury in the rat stomach. Gastroenterology 124(4) 174 (2003). Poster presentation, Digestive Diseases Week, Orlando, USA. May 2003.

36. JL Dyer, RN Butler, CJ Xian and GS Howarth. Partial attenuation of 5-Fluorouracil induced intestinal mucositis by pre-treatment with Insulin-like Growth Factor-I (IGF-I) in rats. Gastroenterology 124(4): 597 (2003). Poster presentation, Digestive Diseases Week, Orlando, USA. May 2003.

37. GS Howarth, B Jones, S Nobbs, H Zola, I Penttila and IA Flesch. Dendritic cells and IBD. Proceedings of Falk IBD Symposium #133 Poster 27– Mechanisms of Intestinal Inflammation: Implications for therapeutic intervention in IBD (2003). Poster presentation, Falk IBD Symposium, Berlin, Germany. May 2003.

38. JC Cool, JL Dyer, CJ Xian, RN Butler, D Tenikoff, MS Geier and GS Howarth. Pre-treatment with Insulin-like Growth Factor-I (IGF-I) partially ameliorates intestinal mucositis in rats. Growth Hormone & IGF Research 14(2): 145 (2004). Poster presentation, International IGF Research Society, Cairns, Qld, April 2004. Also oral presentation Endocrine Society of Australia, Sydney, NSW, September (2004).

39. MS Geier, C Abbott, D Tenikoff, G McCaughan and GS Howarth. Development and resolution of experimental colitis in dipeptidyl peptidase IV knockout mice. Gastroenterology 126(4): A-142 (2004). Poster, Digestive Diseases Week, New Orleans, USA. May 2004.

40. JR Coldwell, GS Howarth and LA Blackshaw. Increased colonic afferent sensitivity to 5-HT in inflammation and recovery. Gastroenterology 126(4): A-94 (2004). Poster presentation, Digestive Diseases Week, New Orleans, USA. May 2004.

41. JR Coldwell, GS Howarth and LA Blackshaw. High threshold rat colonic afferents directly respond to mast cell degranulation in acute inflammation. Gastroenterology 126(4): A-161 (2004). Oral presentation, Digestive Diseases Week, New Orleans, USA. May 2004.

42. JR Coldwell, GS Howarth and LA Blackshaw. Colonic extraluminal mechanoreceptors and inflammation in the rat colon. Gastroenterology 126(4): A-164 (2004). Poster presentation, Digestive Diseases Week, New Orleans, USA. May 2004.

43. D Tenikoff, KJ Murphy, M Le, P Howe and GS Howarth. Lyprinol: a potential preventive treatment for IBD. J. Gastro. Hepatol. 19 A209: 34 (2004). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 2004.

44. MS Geier, CA Abbott, D Tenikoff, K Ajami, G McCaughan, M Gorrell R Yazbek and GS Howarth. Dipeptidyl peptidase IV in induction and resolution of experimental colitis. J. Gastro. Hepatol. 19: A201 (2004). Poster presentation, Australian Gastroenterology Week, Brisbane, Qld. October 2004. Also oral presentation Endocrine Society of Australia, Sydney, NSW, September (2004).

45. R Kamil, JC Cool, JL Dyer, D Tenikoff, RN Butler, CJ Xian, and GS Howarth. Prophylactic administration of Insulin-like Growth Factor-I (IGF-I) reduces the severity of chemotherapy-induced mucositis via modulation of epithelial cell kinetics. J. Gastro. Hepatol. 19: A207 (2004). Poster, Australian Gastroenterology Week, Brisbane, Qld. October 2004.

46. R Yazbeck, H-U Demuth, GS Howarth and CA Abbott. Inhibition of Dipeptidyl Peptidase IV-Like Activity Partially Ameliorates Development of Experimentally-Induced Colitis in Mice. Proceedings of 2nd International conference on Dipeptidyl Aminopeptidases. Magdeburg, Germany, April 2005.

47. R Kamil, RN Butler, MS Geier, and GS Howarth. Severity of Indomethacin-induced Intestinal Ulceration in Rats is Differentially Affected by Lactobacillus and Bifidobacterium Probiotic Species (Hepatology and Luminal Environment Workshop. Gastroenterological Society of Australia, Victor Harbor, SA, 2005).

48. MS Geier, RN Butler, PC Giffard and GS Howarth. Probiotic Species are Differentially Effective in Attenuation of Experimental Colitis. (Hepatology and Luminal Environment Workshop. Gastroenterological Society of Australia, Victor Harbor, SA, 2005).

49. R Yazbeck, MS Geier, CA Abbott, D Tenikoff, G McCaughan, and GS Howarth. Dipeptidyl peptidase inhibition and inflammatory bowel disease.  Gastroenterology. 128 (4): A-200 (2005). (Poster presentation, DDW Chicago 2005).

50. R Kamil, MS Geier, RN Butler and GS Howarth. Probiotic treatments for distal small bowel ulceration.  Gastroenterology. 128 (4): A-604 (2005). (Poster presentation, Australian Gastroenterology Week, Brisbane, Queensland and DDW Chicago 2005). J Gastro Hepatol 20: A29 (2005).

51. MS Geier, R Kamil, RN Butler and GS Howarth. Probiotic treatments for DSS-induced inflammatory bowel disease in rats.  Gastroenterology. 128 (4): A-603 (2005). (Poster presentation, DDW Chicago 2005).

52. KL Inglis, RN Butler, GP Davidson and GS Howarth. Use of the sucrose breath test to monitor gut side-effects of different classes of chemotherapy drugs. Gastroenterology. 128 (4): A-552 (2005). (Poster presentation, DDW Chicago 2005).

53. MS Geier, R Yazbeck, H-U Demuth, CA Abbott and GS Howarth. Inhibition of Dipeptidyl Peptidase IV-Like Activity Partially Prevents Development of Experimentally-Induced Colitis in Mice. (Oral presentation, ASMR (SA) Conference, Adelaide, SA and Poster presentation, Falk IBD Symposium, Birmingham, UK, 2005).

54. MS Geier, RN Butler, PC Giffard and GS Howarth. Differential Efficacy of Probiotic Species in Amelioration of Dextran Sulphate Sodium-Induced Colitis in Rats (Oral presentation, ASMR (SA) Conference, Adelaide, SA and Poster presentation, Australian Gastroenterology Week, Brisbane, Queensland and Falk IBD Symposium, Birmingham, UK, 2005). J Gastro Hepatol 20: A33 (2005).

55. KL Inglis, KA Penning, GS Howarth and RN Butler. Oral ingestion of Streptococcus thermophilus partially attenuates methotrexate-induced small intestinal mucositis in rats (Oral presentation, Multinational Association of Supportive Care in Cancer, 17th International Symposium, Geneva Switzerland, 2005).

56. GM Matthews, GS Howarth and RN Butler. Butyrate is more potent than propionate at increasing activity of the oxidative pentose pathway in the Kato-III gastric cancer cell line. (Oral presentation, ASMR (SA) Conference, Adelaide, SA and (Poster presentation, Australian Gastroenterology Week, Brisbane, Queensland and World Congress of Gastroenterology, Montreal, Canada, 2005). J Gastro Hepatol 20: A109 (2005).

57. GM Matthews, GS Howarth and RN Butler. Butyrate and propionate increase apoptotic rate in Kato-III gastric cancer cells. (Poster presentation, Australian Gastroenterology Week, Brisbane, Queensland and World Congress of Gastroenterology, Montreal, Canada, 2005) J Gastro Hepatol 20: A109 (2005).

58. R Yazbeck, GS Howarth, H-U Demuth, MS Geier and CA Abbott.  Inhibition of Dipeptidyl Peptidase IV-Like Activity Partially Ameliorates Development of Experimentally Induced Colitis in Mice. (Poster presentation, "Inflammatory bowel disease: Research drives clinics" Muenster, Germany, New York Academy of Sciences A158 (2005). Oral presentation, Australian Gastroenterology Week, Brisbane, Queensland, and Oral presentation, 5th General Meeting of the International Proteolysis Society, Quebec, Canada 2005). J Gastro Hepatol 20: A23 (2005).

59. ALK Roberts, JM Fletcher, GS Howarth, KA Lymn and S Byers.  Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA (MPS IIIA). (Poster presentation, Australia and New Zealand Matrix Biology Society, Victor Harbor, South Australia (2005).

60. GS Howarth, KL Inglis GP Davidson and RN Butler.  Applicability of the Sucrose Breath Test to detect mucositis manifest by different classes of chemotherapy drugs. (Poster presentation, Australian Gastroenterology Week, Brisbane, Queensland, 2005) J Gastro Hepatol 20: A38 (2005).

61. KL Inglis, GS Howarth, KA Lymn, A Lawrence and RN Butler.  Oral ingestion of Streptococcus thermophilus partially-attenuates methotrexate-induced small bowel damage in female dark agouti rats. Falk IBD Symposium No. 151: A48. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

62. CL Smith, MS Geier, JML Chapman, K Roberts, RN Butler and GS Howarth, Dextran Sulphate Sodium (DSS)-induced small intestinal hyperplasia is prevented by administration of Lactobacillus Fermentum to rats. Falk IBD Symposium No. 151: A49. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

63. JM Ball, CD Tran and GS Howarth.  Effects of zinc supplements on severity of experimental colitis in mice Falk IBD Symposium No. 151: A50. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

64. MS Geier, RN Butler, PM Giffard and GS Howarth.  Fructooligosaccharide alone and as a synbiotic, exacerbates severity of experimental colitis in rats. Falk IBD Symposium No. 151: A47. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

65. R Kamil, MS Geier, RN Butler and GS Howarth.  Differential effects of probiotics on severity of indomethacin-induced small bowel enteropathy. Falk IBD Symposium No. 151: A53. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

66. R Yazbeck, GS Howarth, H-U Demuth and CA Abbott.  Inhibitors of dipeptidyl peptidase IV decrease symptoms of experimental colitis in mice. Falk IBD Symposium No. 151: A54. Emerging Issues in Inflammatory Bowel Disease, Sydney, March 2006 and Gastroenterology 130 (4): A345 (2006) - Digestive Diseases Week, Los Angeles (May 2006).

67. CA Mauger, RN Butler, MS Geier, KL Inglis and GS Howarth.  Use of the sucrose breath test to assess probiotic efficacy in chemotherapy-induced small bowel injury. Falk IBD Symposium No. 151: A28. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

68. GM Matthews, GS Howarth and RN Butler. Butyrate and propionate increase apoptotic rate in Kato-III gastric cancer cells. Lorne Cancer Conference, Lorne, Victoria (February 2006).

69. L Philp, N Nair, R Yazbeck, CA Abbott and GS Howarth.  Inhibition of Dipeptidyl Peptidase IV Like Activity Fails To Enhance Jejunal Growth In Mice With Experimentally-Induced Colitis. Falk IBD Symposium No. 151: A58. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

70. D Tenikoff, MS Geier, KJ Murphy, M Le, P Howe and GS Howarth. Lyprinol: a potential preventive treatment for IBD. Falk IBD Symposium No. 151: A59. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006).

71. ML Sulda, R Yazbeck, GS Howarth and CA Abbott. Dipeptidyl peptidases in a murine model of IBD. Falk IBD Symposium No. 151: A88. Emerging Issues in Inflammatory Bowel Disease, Sydney, (March 2006) and Gastroenterology 130 (4): A347 (2006) - Digestive Diseases Week, Los Angeles (May 2006).

72. GS Howarth. Translation of Complex Scientific Seminars to Undergraduate Lecture Format: an Opportunity to Develop Student Mentorship and Leadership Skills. ‘Investigations into University Learning and Teaching’. Tri-institutional Symposium. Flinders University (February 2006).

73. RN Butler, KL Tooley, GP Davidson and GS Howarth. Combinations of non-invasive biomarkers to assess gut altered by chemotherapy or infection. Biomarker World Congress, Philadelphia, USA (May 2006).

74. REA Forder, DR Tivey, GS Howarth and RJ Hughes. Changes in ileal mucin production through interactions with intestinal microflora during early post-hatch development of poultry. Australian Society for Medical Research – SA (p22), Adelaide (June 2006).

75. VA Torok, K Ophel-Keller, GS Howarth and RJ Hughes. Relationship between intestinal microbial species and growth performance in broiler chickens. Australian Society for Medical Research – SA (p32), Adelaide (June 2006).

76. MS Geier, RN Butler and GS Howarth. Supplementation with the prebiotic fructo-oligosaccharide increases the severity of experimental colitis in rats. Australian Society for Medical Research – SA (p44), Adelaide (June 2006).

77. R Kamil, MS Geier, RN Butler and GS Howarth.  Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a rat model of indomethacin-induced enteropathy. Australian Society for Medical Research – SA (p45), Adelaide (June 2006).

78. GM Matthews, JW Wilson, GS Howarth and RN Butler. Up-regulation of intracellular protective mechanisms in gastric cancer cells following exposure to sodium butyrate. Australian Society for Medical Research – SA (p48), Adelaide (June 2006).

79. CA Mauger, RN Butler, MS Geier, KL Inglis and GS Howarth.  Use of the sucrose breath test to assess probiotic effects on small bowel injury in the rat.  Australian Society for Medical Research – SA (p49), Adelaide (June 2006).

80. L Philp, N Nair, R Yazbeck, CA Abbott and GS Howarth.  Inhibition of Dipeptidyl Peptidase IV Like Activity Fails To Enhance Jejunal Growth In Mice With Experimentally-Induced Colitis. Australian Society for Medical Research – SA (p53), Adelaide (June 2006).

81. CL Smith, MS Geier, JML Chapman, K Roberts, RN Butler and GS Howarth, Administration of Lactobacillus Fermentum BR11 to rats prevents DSS-induced small intestinal hyperplasia. Australian Society for Medical Research – SA (p55), Adelaide (June 2006).

82. ML Sulda, R Yazbeck, GS Howarth and CA Abbott. Dipeptidyl peptidases in a murine model of IBD. Australian Society for Medical Research – SA (p56), Adelaide (June 2006).

83. CD Tran, JM Ball and GS Howarth.  The role of zinc supplementation on the alleviation of DSS-induced colitis in the mouse.  Australian Society for Medical Research – SA (p58), Adelaide (June 2006).

84. R Yazbeck, GS Howarth, H-U Demuth and CA Abbott.  Inhibition of dipeptidyl peptidase IV in DPIV knock-out and wild-type mice decreases disease activity in experimental colitis. Australian Society for Medical Research – SA (p61), Adelaide (June 2006).

85. RN Butler, S Kritas, KL Tooley, KA Lymn and GS Howarth. Combinations of non-invasive tests to assess gut dysfunction induced by chemotherapy and infection. Supportive Care in Cancer, 14(6): 611 (06-049). Multinational Association of Supportive Care in Cancer, 18th International Symposium, Toronto, Ontario, Canada (June 2006).

86. GS Howarth, KL Tooley, GP Davidson, KA Lymn and RN Butler. Non-invasive monitoring of intestinal mucositis using the 13C-sucrose breath test (SBT): a new biomarker for drug discovery. Supportive Care in Cancer, 14(6): 638 (16-111). Multinational Association of Supportive Care in Cancer, 18th International Symposium, Toronto, Ontario, Canada (June 2006).

87. GM Matthews, GS Howarth and RN Butler. Short-chain fatty acid modulation of apoptosis and cell cycle in Kato III gastric cancer cells. 4th International Conference on Gastrointestinal Carcinogenesis, Hawaii, USA (August 2006).

88. VA Torok, K Ophel-Keller, GS Howarth and RJ Hughes. Broiler chickens as a model to investigate diet induced changes in gut microflora. (Poster presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A264 (2006).

89. REA Forder, DR Tivey, GS Howarth and RJ Hughes. Changes in ileal mucin production through interactions with intestinal microflora during early post-hatch development of poultry. (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A265 (2006).

90. CL Smith, MS Geier, JML Chapman, K Roberts, RN Butler and GS Howarth, Dextran Sulphate Sodium (DSS)-induced small intestinal hyperplasia is prevented by administration of Lactobacillus Fermentum to rats. (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A268 (2006).

91. R Yazbeck, GS Howarth, H-U Demuth, JJ Holst, D Marguet and CA Abbott.  Inhibition of dipeptidyl peptidase activity in DPIV knock-out and wild-type mice decreases disease activity in experimental colitis. (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A273 (2006).

92. CD Tran, JM Ball, S Sundar and GS Howarth.  Time-course of dextran sulfate sodium (DSS)-induced colitis in metallothionein (MT) null (MT-/-) mice. (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A283 (2006).

93. CA Mauger, RN Butler, MS Geier, KL Tooley and GS Howarth.  Use of the sucrose breath test to assess probiotic effects on small bowel injury in the rat.  (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A284 (2006).

94. CD Tran, JM Ball, S Sundar and GS Howarth.  Zinc supplementation and metallothionein (MT) in dextran sulfate sodium (DSS)-induced ulcerative colitis. (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A347 (2006).

95. GM Matthews, GS Howarth and RN Butler. Short-chain fatty acid modulation of cell cycle in Kato-III gastric cancer cells. (Oral presentation: Australian Gastroenterology Week, Adelaide, SA, October 2006). J Gastro Hepatol 21(4): A360 (2006).

96. G Brooke, F Dunshea, J Pluske, D Pethick, GS Howarth and R Campbell. Investigating the inclusion of fat in the diet of grower and finishing pigs. (Oral presentation: Proceedings of 2nd Pork CRC Conference, Melbourne, Vic, November 2006).

97. J Fauser, AG Cummins, RN Butler, R Campbell and GS Howarth. Fatty acid modulation of porcine enterocyte function. (Oral presentation: Proceedings of 2nd Pork CRC Conference, Melbourne, Vic, November 2006).

98. GM Matthews, GS Howarth and RN Butler. Inhibition of intracellular protection enhances the sensitivity of Kato III gastric cancer cells to SCFA-induced apoptosis. (Poster presentation. Lorne Cancer Conference, Lorne, Vic, February 2007).

99. R Yazbeck, GS Howarth, H-U Demuth, JJ Holst, D Marguet and CA Abbott.  Inhibition of Dipeptidyl Peptidase Activity Increases Circulating Glucagon-like Peptide-2 and Decreases Neutrophil Infiltration during Experimental Colitis in Mice. (Poster presentation. Digestive Diseases Week, Washington DC, USA, May 2007). Gastroenterology 132(4): Supplement 2: A-369 (2007).

100. CL Smith, RN Butler and GS Howarth. Lactobacillus fermentum BR11 and Fructo-oligosaccharide Partially Reduce Jejunal Inflammation but not Overall Damage Severity of 5-Flourouracil-Induced Mucositis in Rats. (Poster presentation. Digestive Diseases Week, Washington DC, USA, May 2007). Gastroenterology 132(4): Supplement 2: A-714 (2007).

101. CL Smith, MS Geier, RN Butler and GS Howarth. Dextran Sulfate Sodium-Induced Crypt Hyperplasia in the Jejunum and Ileum is Partially-Prevented by Oral Administration of Lactobacillus fermentum BR11 and Bifidobacterium lactis Bb12 to Rats. (Poster presentation. Digestive Diseases Week, Washington DC, USA, May 2007). Gastroenterology 132(4): Supplement 2: A-370 (2007).

102. DM Torres, RN Butler and GS Howarth. Lyprinol (stabilised lipid extract of New Zealand green-Lipped Mussel) Partially-Protects from 5-Fluorouracil-induced mucositis in Rats. (Poster presentation. Digestive Diseases Week, Washington DC, USA, May 2007). Gastroenterology 132(4): Supplement 2: A-570 (2007).

103. REA Forder, DR Tivey, GS Howarth, G Firth and RJ Hughes. Changes in ileal mucin production through interactions with intestinal microflora during early post-hatch development of poultry. (Poster presentation. Digestive Diseases Week, Washington DC, USA, May 2007). Gastroenterology 132(4): Supplement 2: A-551 (2007).

104. ALK Roberts, S Moretta, JM Fletcher, GS Howarth, KA Lymn and S Byers. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA (MPS IIIA). (Poster presentation. Digestive Diseases Week, Washington DC, USA, May 2007). Gastroenterology 132(4): Supplement 2: A-537 (2007).

105. RN Butler, GS Howarth, MS Geier, R Yazbeck, CL Smith, KA Lymn, GP Davidson and L Borges. Palifermin regulates intestinal function and protects against 5-FU-induced mucositis. (Poster presentation at Multi-National Association of Supportive Care in Cancer, St Gallen, Switzerland, June 2007).

106. T Price, L Morelli, GS Howarth, J Webster, B Zacharakis, C Brooker, DM Keefe, P Bardy, KL Tooley, GP Davidson, RN Butler. Residual damage to the small intestine induced by chemotherapy can be detected and monitored using the non-invasive 13C sucrose breath test (SBT) (European Association for Cancer Research, ECCO 14, Barcelona, Spain, September 2007). EJC Supplements 5(4): 152 (2007).

107. R Yazbeck, GS Howarth, H-U Demuth, JJ Holst and CA Abbott. Inhibition of Dipeptidyl Peptidase Activity Increases Circulating Glucagon-like Peptide-2 and Partially Attenuates Neutrophil Infiltration during Experimental Colitis in Mice. (Hepatology and Luminal Research Workshop, Hunter Valley, NSW, June 2007).

108. MS Geier, RN Butler, PM Giffard and GS Howarth. Supplementation with the prebiotic fructo-oligosaccharide increases the severity of experimental colitis in rats. (Hepatology and Luminal Research Workshop, Hunter Valley, NSW, June 2007).

109. JK Fauser, GS Howarth, RN Butler and AG Cummins. Effect of blockade of wnt signalling during postnatal growth of the small intestine. (Oral 16: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

110. JK Fauser, RN Butler, AG Cummins and GS Howarth. Medium-chain fatty acid induction of cell death in the Caco-2 and IEC-6 cell lines. (Poster 17: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

111. DM Torres, RN Butler, KL Tooley, CL Smith, MS Geier and GS Howarth. Lyprinol (stabilised lipid extract of New Zealand green-Lipped Mussel) Partially-Protects from 5-Fluorouracil-induced mucositis in Rats. (Poster 46: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

112. CL Smith, RN Butler, R Yazbeck, DM Torres, MS Geier and GS Howarth. Lactobacillus fermentum BR11 and Fructo-oligosaccharide Partially Reduce Jejunal Inflammation but not Overall Damage Severity of 5-Flourouracil-Induced Mucositis in Rats. (Poster 44: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

113. R Yazbeck, CA Abbott, S Mashtoub, A Wendland, M Leach, R Jennings, H-U Demuth, D Marguet and GS Howarth. Dextran Sulphate Sodium Induced Colitis Modifies Small Intestinal Villus Height and Crypt Depth Potentially Regulated by Dipeptidyl Peptidase Activity. (Oral 48: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

114. R Yazbeck, GS Howarth, H-U Demuth, JJ Holst and CA Abbott. Inhibition of Dipeptidyl Peptidase Activity Increases Circulating Glucagon-like Peptide-2 and Decreases Neutrophil Infiltration during Experimental Colitis in Mice. (Oral 47: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

115. G. Brooke, A.C. Edwards, J.R. Pluske, G.S. Howarth, R.G. Campbell and F.R. Dunshea. Pig – The ideal model of Dietary Fat and Obesity related problems. (Oral 7: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007).

116. S Sundar, CD Tran and GS Howarth. Dietary zinc supplementation and methotrexate-induced small intestinal mucositis in metallothionein-knock out and wild type mice. Poster 47: Australian Society for Medical Research – SA Section, Adelaide, SA, June 2007; and FASEB Journal 21(6): A1120 (2007).

117. G Brooke, AC Edwards, JR Pluske, GS Howarth, RG Campbell and FR Dunshea. Supplemental dietary fat increases growth performance of grower and finisher pigs. (11th Biennial Conference of the Australasian Pig Science Association, Brisbane, Queensland, November 2007).

118. DM Torres, RN Butler, KL Tooley, CL Smith, MS Geier and GS Howarth. Lyprinol (stabilised lipid extract of New Zealand Green-Lipped Mussel) Partially-Protects from 5-Fluorouracil-induced mucositis in Rats. (Oral Presentation, Australian Gastroenterology Week, Perth, WA, October 2007). J Gastro Hepatol 22(3): A309 (2007).

119. JK Fauser, GS Howarth, RN Butler and AG Cummins. Effect of blockade of wnt signalling during postnatal growth of the small intestine. (Poster Presentation, Lorne Cancer Conference (2008) and Australian Gastroenterology Week, Perth, WA, October 2007). J Gastro Hepatol 22(3): A324 (2007).

120. CL Smith, RN Butler and GS Howarth. Lactobacillus fermentum BR11 and Fructo-oligosaccharide Partially Reduce Jejunal Inflammation but not Overall Damage Severity of 5-Flourouracil-Induced Mucositis in Rats. (Poster Presentation, Australian Gastroenterology Week, Perth, WA, October 2007). J Gastro Hepatol 22(3): A308 (2007).

121. JK Fauser, RN Butler, AG Cummins, GM Matthews and GS Howarth. Medium-chain fatty acid induction of cell death in the Caco-2 and IEC-6 cell lines. (Poster Presentation: Lorne Cancer Conference (2008) and Oral Presentation, Australian Gastroenterology Week, Perth, WA, October 2007). J Gastro Hepatol 22(3): A408 (2007).

122. R Yazbeck, CA Abbott, S Mashtoub, A Wendland, M Leach, R Jennings, H-U Demuth, D Marguet and GS Howarth. Dextran Sulphate Sodium Induced Colitis Modifies Small Intestinal Villus Height and Crypt Depth Potentially Regulated by Dipeptidyl Peptidase Activity (Poster Presentation, Australian Gastroenterology Week, Perth, WA, October 2007; also Falk IBD Conference, Dresden, Germany, October 2007). J Gastro Hepatol 22(3): A301 (2007).

123. R Yazbeck, GS Howarth, H-U Demuth, JJ Holst and CA Abbott. Inhibition of Dipeptidyl Peptidase Activity Increases Circulating Glucagon-like Peptide-2 and Decreases Neutrophil Infiltration during Experimental Colitis in Mice. (Poster Presentation, Australian Gastroenterology Week, Perth, WA; also Falk IBD Conference, Dresden, Germany; and 5th annual meeting of the International Proteolysis Society, Patras, Greece, October 2007). J Gastro Hepatol 22(3): A306 (2007).

124. GM Matthews, GS Howarth and RN Butler. Differential induction of apoptosis by butyrate in Kato-III and Caco-2 cells is related to the rate of butyrate metabolism and p53 status. (Poster Presentation, Australian Gastroenterology Week, Perth, WA, October 2007). J Gastro Hepatol 22(3): A302 (2007).

125. K Brice, KA Lymn, SJ Pain, RN Butler and GS Howarth. Effects of fasting and diet on the 13C-sucrose breath test in rats. (Australian and New Zealand Laboratory Animal Association Inaugural Conference, Adelaide, SA, September 2007).

126. BM Konsak, TM Crowley, RJ Hughes, GS Howarth and RJ Moore. Gene expression studies in the functionally-mature intestinal tract of the chicken. (Oral Presentation, CSIRO Avian Immunology Conference, Gold Coast, Queensland (June 2008) and 23rd World’s Poultry Congress, Brisbane, Queensland, July 2008). World’s Poultry Science Journal 64 (2): 120 (2008).

127. JK Fauser, GS Howarth, RN Butler and AG Cummins. Effect of blockade of wnt signalling during postnatal growth of the small intestine. (Poster Presentation, Digestive Diseases Week, San Diego, Ca, USA, May 2008). Gastroenterology 134(4): Supplement 1: A-574 (2008).

128. REA Forder, C Masselot-Robbe, GS Howarth and RJ Hughes. Influence of bacterial colonisation on glycosylation of intestinal mucin oligosaccharides during early development. (Poster Presentation, Digestive Diseases Week, San Diego, Ca, USA, May 2008). Gastroenterology 134(4): Supplement 1: A-707 (2008). (Oral Presentation, 23rd World’s Poultry Congress, Brisbane, July 2008). World’s Poultry Science Journal 64 (2): 366 (2008).

129. KY Cheah, SEP Bastian, RN Butler, C Payne, KA Lymn, R Yazbeck, TH Wright, EJ Whitford, GR Sander and GS Howarth. An extract from grape seed protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. (Poster Presentation, Digestive Diseases Week, San Diego, Ca, USA, May 2008). Gastroenterology 134(4): Supplement 1: A-530 (2008).

130. TH Wright, RN Butler, KA Lymn, R Yazbeck, KY Cheah, EJ Whitford, GR Sander and GS Howarth. The herbal extract, Iberogast, partially improves small intestinal integrity in rats with mucositis induced by 5-Fluorouracil. (Poster Presentation, Digestive Diseases Week, San Diego, Ca, USA, May 2008). Gastroenterology 134(4): Supplement 1: A-530 (2008).

131. R Yazbeck, CA Abbott, S Mashtoub, A Wendland, M Leach, R Jennings, H-U Demuth, D Marguet and GS Howarth. Dextran Sulphate Sodium Induced Colitis Modifies Small Intestinal Villus Height and Crypt Depth Potentially Regulated by Dipeptidyl Peptidase Activity (Poster Presentation, Digestive Diseases Week, San Diego, Ca, USA, May 2008). Gastroenterology 134(4): Supplement 1: A-525 (2008).

132. R Yazbeck, M Sulda, GS Howarth, JJ Holst, HU Demuth and CA Abbott. Resolving how inhibition of Dipeptidyl Peptidase Activity can ameliorate DSS-induced colitis in mice (Ross Wishart award finalist RW4 - Oral Presentation, Australian Society for Medical Research – SA Section, Adelaide, June 2008). Oral Presentation, Australian Gastroenterology Week, Brisbane, October 2008. J Gastro Hepatol 23(4): A210 (2008).

133. EJ Whitford, AG Cummins, RN Butler, KA Lymn, JK Fauser, R Yazbeck, A Lawrence, KY Cheah, TH Wright, KL Tooley, L Prisciandaro and GS Howarth. Effects of the new probiotic Streptococcus thermophilus TH-4, and its derivatives, on severity of mucositis induced by 5-Fluorouracil in rats. (Poster Presentation P36: Australian Society for Medical Research – SA Section, Adelaide, June 2008 and Oral Presentation, Australian Gastroenterology Week, Brisbane, October 2008). J Gastro Hepatol 23(4): A294 (2008).

134. TH Wright, RN Butler, KA Lymn, R Yazbeck, KY Cheah, EJ Whitford, GR Sander, S Mashtoub and GS Howarth. The herbal extract, Iberogast, partially improves small intestinal integrity in rats with mucositis induced by 5-Fluorouracil. (Poster Presentation P34: Australian Society for Medical Research – SA Section, Adelaide, June 2008 and Poster Presentation Australian Gastroenterology Week, Brisbane, October 2008). J Gastro Hepatol 23(4): A200 (2008).

135. KY Cheah, SEP Bastian, RN Butler, C Payne, KA Lymn, R Yazbeck, TH Wright, EJ Whitford, GR Sander and GS Howarth. An extract from grape seed protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. (Poster Presentation P29: Australian Society for Medical Research – SA Section, Adelaide, June 2008 and Poster Presentation and Poster of Merit, Australian Gastroenterology Week, Brisbane, October 2008). J Gastro Hepatol 23(4): A204 (2008).

136. RJ Lindsay, MS Geier, RN Butler and GS Howarth. Effects of Emu Oil on small intestinal integrity in rats with mucositis induced by 5-Fluorouracil. (Oral Presentation O40: Australian Society for Medical Research – SA Section, Adelaide, June 2008; also Oral and Poster Presentations, 4th International Ratite Scientific Symposium, Brisbane, July 2008 World’s Poultry Science Journal 64 (2): 670 (2008) and Oral Presentation Australian Gastroenterology Week, Brisbane, October 2008. J Gastro Hepatol 23(4): A211 (2008). Poster Presentation: Digestive Diseases Week, Chicago, USA.  Gastroenterology 136(5): A-717 (2009).

137. RN Butler, GS Howarth, R Yazbeck, KA Lymn, GP Davidson and L Borges. SBT index for rapid detection of new bioactives in intestinal mucositis. Poster Presentation Australian Gastroenterology Week, Brisbane, October 2008. J Gastro Hepatol 23(4): A205 (2008).

138. GS Howarth, RJ Lindsay, RN Butler and MS Geier. Can Emu Oil ameliorate inflammatory disorders affecting the gastrointestinal system?. (Oral Presentation, 4th International Ratite Scientific Symposium, Brisbane, July 2008). World’s Poultry Science Journal 64 (2): 669 (2008).

139. LD Prisciandaro, JK Fauser, RN Butler, AG Cummins and GS Howarth. Soluble products secreted from the newly identified probiotic, Lactobacillus fermentum BR11, improves viability of rat intestinal cells. Oral Presentation. Nutrition Society of Australia, 32nd Annual Scientific Meeting, Adelaide, December 2008. Asia Pacific Journal of Clinical Nutrition 17 (3): S57 (2008).

140. S Mashtoub, RJ Lindsay, KA Lymn, TMJ Acott, AG Cummins, RN Butler and GS Howarth.  Emu Oil improves aspects of colonic integrity in a rat model of ulcerative colitis. Poster Presentation. Nutrition Society of Australia, 32nd Annual Scientific Meeting, Adelaide, December 2008. Asia Pacific Journal of Clinical Nutrition 17 (3): S48 (2008).

141. GS Howarth, RJ Lindsay, KY Cheah, KL Tooley and RN Butler. Bioactive factors and bowel disease. Invited Oral Presentation. Nutrition Society of Australia, 32nd Annual Scientific Meeting, Adelaide, December 2008. Asia Pacific Journal of Clinical Nutrition 17 (3): S37 (2008).

142. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Factors secreted from Lactobacillus fermentum BR11 and Escherichia coli Nissle 1917 as a potential therapy for 5-Fluorouracil induced mucositis: a pilot study. Poster Presentation. Multinational Association of Supportive Care in Cancer, Rome, Italy. Supportive Care in Cancer 17(7): 913 (2009).

143. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Compounds secreted from Escherichia coli Nissle 1917, Streptococcus thermophilus TH-4 and Lactobacillus fermentum BR11 maintain intestinal cell viability following 5-Fluorouracil administration in vitro. Poster Presentation. Multinational Association of Supportive Care in Cancer (MASCC) and also Oral Presentation, MASCC Mucositis Satellite Workshop, Rome, Italy. Supportive Care in Cancer 17(7): 913 (2009).

144. KY Cheah, SEP Bastian, TMV Acott, RN Butler and GS Howarth. Grape Seed Extract and alleviation of chemotherapy-induced intestinal injury and inflammatory bowel disease. Poster Presentation. Multinational Association of Supportive Care in Cancer (MASCC) and also Oral Presentation, MASCC Mucositis Satellite Workshop, Rome, Italy. Supportive Care in Cancer 17(7): 905 (2009).

145. S Mashtoub, RJ Lindsay, RN Butler and GS Howarth. Emu Oil promotes repair from chemotherapy-induced intestinal injury and large bowel inflammation. Poster Presentation. Multinational Association of Supportive Care in Cancer, Rome, Italy. Supportive Care in Cancer 17(7): 910 (2009).

146. JK Fauser, RN Butler, AG Cummins, GM Matthews and GS Howarth. Fatty acids: Novel anti-cancer therapeutics. Poster Presentation: World Congress on Oils and Fats, Sydney, Australia (2009).

147. BM Konsak, TM Crowley, RJ Hughes, GS Howarth and RJ Moore.  Gene expression studies in the naïve and mature ileum of the chicken. 17th European Symposium on Poultry Nutrition, Edinburgh, United Kingdom (2009).

148. S Mashtoub, RJ Lindsay, KA Lymn, TWV Acott, R Yazbeck, AG Cummins, RN Butler and GS Howarth. Emu oil increases crypt depth but fails to affect other indicators of colonic integrity in a rat model of colitis. Oral Presentation O28 Australian Society for Medical Research – SA Section, Adelaide, South Australia and Oral Presentation, World Congress on Oils and Fats, Sydney, Australia (2009).

149. R Yazbeck, GS Howarth, RN Butler, MS Geier and CA Abbott. Dipeptidyl peptidase-IV inhibitors and small intestinal adaptations during experimental colitis. Oral Presentation O26: Australian Society for Medical Research – SA Section, Adelaide, South Australia; also Hepatology and Luminal Research Workshop. Yarra Valley, Victoria, Australia (2009).

150. M Vu, B Hoang, XD Ding, M Sultani, S Mashtoub, RJ Lindsay, KA Lymn, RN Butler and GS Howarth. A safety study of Emu Oil as a potential adjunctive treatment for Ulcerative Colitis and Mucositis. Poster Presentation P33: Australian Society for Medical Research – SA Section, Adelaide, South Australia (2009).

151. KY Cheah, SEP Bastian, TMV Acott, RN Butler and GS Howarth. Grape Seed Extract and alleviation of chemotherapy-induced intestinal injury and inflammatory bowel disease. Poster Presentation P40: Australian Society for Medical Research – SA Section, Adelaide, South Australia (2009).

152. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Compounds secreted from Escherichia coli Nissle 1917, Streptococcus thermophilus TH-4 and Lactobacillus fermentum BR11 maintain intestinal cell viability following 5-Fluorouracil administration in vitro. Oral Presentation O12: Australian Society for Medical Research – SA Section, Adelaide, South Australia (2009).

153. JK Fauser, RN Butler, AG Cummins and GS Howarth. Fatty acids: Novel anti-cancer therapeutics. Oral Presentation O31: Australian Society for Medical Research – SA Section, Adelaide, South Australia (2009).

154. RR Nadhanan, MA Scherer, GS Howarth, RJ Lindsay, T Shandala and CJ Xian. Dietary Emu Oil supplementation may suppress 5-Fluorouracil chemotherapy-induced formation of bone resorptive cells (osteoclasts). Oral Presentation O39: Australian Society for Medical Research – SA Section, Adelaide, South Australia (2009).

155. CJ Xian, CM Fan, JC Cool, MA Scherer, T King, K Georgiou, RR Nadhanan, GS Howarth, T Shandala and BK Foster. Pathophysiology and prevention of cancer chemotherapy-induced bone growth defects. Bone 45(2): S103 (2009).

156. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Probiotic factors maintain intestinal cell viability following 5-Fluorouracil administration in vitro. Oral Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, Australia. J Gastro Hepatol 24(2): A328 (2009).

157. S Mashtoub, RJ Lindsay, KA Lymn, TWV Acott, R Yazbeck, AG Cummins, RN Butler and GS Howarth. Emu oil increases crypt depth but fails to affect other indicators of colonic integrity in a rat model of colitis. Poster Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, Australia. J Gastro Hepatol 24(2): A243 (2009).

158. JK Fauser, RN Butler, AG Cummins and GS Howarth. Fatty acids: Novel anti-cancer therapeutics. Poster Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, Australia. J Gastro Hepatol 24(2): A328 (2009).

159. KY Cheah, SEP Bastian, TMV Acott, RN Butler and GS Howarth. Effects of Grape Seed Extract in a rat model of inflammatory bowel disease. Poster Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, Australia. J Gastro Hepatol 24(2): A243 (2009).

160. CD Tran, S Sundar, GS Howarth and RN Butler.  Use of the 13c-sucrose breath test to assess small bowel integrity in methotrexate-induced mucositis following zinc supplementation in metallothionein-knockout and wild-type mice. Oral Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, Australia. J Gastro Hepatol 24(2): A328 (2009).

161. M Vu, B Hoang, XD Ding, M Sultani, S Mashtoub, RJ Lindsay, KA Lymn, RN Butler and GS Howarth. A safety study of Emu Oil as a potential adjunctive treatment for Ulcerative Colitis and Mucositis. Poster Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, Australia. J Gastro Hepatol 24(2): A240 (2009).

162. R Yazbeck, GS Howarth, RN Butler, MS Geier and CA Abbott. Dipeptidyl peptidase-IV inhibitors and small intestinal adaptations during experimental colitis. Oral Presentation. Australian and New Zealand Medical and Surgical Gastrointestinal Week. Sydney, New South Wales, J Gastro Hepatol 24(2): A336 (2009); also 6th General Meeting of the International Proteolysis Society. Gold Coast, Queensland (2009).

163. GS Howarth. Bioactive factors and bowel disease. Oral Presentation. The Enteric Nervous System Workshop (Proceedings). Adelaide, South Australia (2009).

164. R Yazbeck, GS Howarth, RN Butler, MS Geier and CA Abbott. Dipeptidyl peptidase-IV inhibitors and small intestinal adaptations during experimental colitis. Digestive Diseases Week, New Orleans, USA (2010).

165. CD Tran, GS Howarth and RN Butler. Use of the sucrose breath test to assess methotrexate-induced mucositis following zinc supplementation. Experimental Biology 2010. Anaheim, USA (2010).

166. BM Konsak, TM Crowley, RJ Hughes, GS Howarth and RJ Moore. Understanding the Transition from the Naïve Gut to the Functionally Mature Gut. 13th European Poultry Conference, Aix-En-Provence Area, Tours, France (2010).

167. RR Nadhanan, MA Scherer, T Shandala, Y-W Su, GS Howarth, S Mashtoub and CJ Xian. Dietary Emu Oil supplementation may suppress chemotherapy-induced formation of bone-resorptive cells osteoclasts and prevent bone loss. Australian Society for Medical Research (SA Section) (2010).

168. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Pre-treatment with probiotic factors protects intestinal cells from 5-Fluorouracil induced changes in transepithelial resistance and caspase 3/7 activation. Oral Presentation O2. Australian Society for Medical Research (SA Section) (2010).

169. B Hoang, S Mashtoub, M Vu, KA Lymn, RN Butler, R Yazbeck and GS Howarth. A Traditional Chinese Medicine Formulation Partially Normalises Crypt Architecture in Experimental Colitis. Oral Presentation P10. Australian Society for Medical Research (SA Section) (2010).

170. M Vu, S Mashtoub Abimosleh, B Hoang, KA Lymn, C Feinle-Bisset and GS Howarth. Clinical, structural and biochemical effects of the multi-herb extract, Iberogast, in an experimental model of ulcerative colitis. Poster Presentation P29. Australian Society for Medical Research (SA Section) (2010).

171. KY Cheah, GS Howarth and SEP Bastian. Grape Seed Extract improves parameters of small intestinal mucositis in rats in a dose responsive manner. Oral Presentation O3. Australian Society for Medical Research (SA Section) (2010).

172. GS Howarth, J Woenig, R Donato, P Grover and AG Cummins. Inhibition of Notch signalling by the gamma-secretase inhibitor, DAPT, decreases postnatal intestinal growth in the rat. Poster Presentation P52. Australian Society for Medical Research (SA Section); also Poster Presentation, Australian Gastroenterology Week, Gold Coast, Queensland. J Gastro Hepatol 25(3): A11 (2010).

173. J McNicholl, P Stott, GS Howarth and S Hazel. Heat stress in canine athletes. Poster Presentation. Universities Federation for Animal Welfare, York, United Kingdom (2010).

174. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Pre-treatment with probiotic factors protects intestinal cells from 5-Fluorouracil induced changes in transepithelial resistance and caspase 3/7 activation. Poster Presentation, Australian Gastroenterology Week, Gold Coast, Queensland. J Gastro Hepatol 25(3): A112 (2010).

175. S Mashtoub Abimosleh, RN Butler and GS Howarth. Emu oil effects on intestinal repair in the rat. Poster Presentation, Australian Gastroenterology Week, Gold Coast, Queensland.  J Gastro Hepatol 25(3): A12 (2010).

176. H Atkins, MS Geier, A Pattanaik, REA Forder, R Yazbeck, RN Butler and GS Howarth. Effects of the CyuC mutant probiotic on experimental colitis in rats. Poster Presentation and Poster of Merit, Australian Gastroenterology Week, Gold Coast, Queensland. J Gastro Hepatol 25(3): A17 (2010).

177. B Hoang, M Vu, S Mashtoub, KA Lymn, RN Butler, R Yazbeck and GS Howarth. Effects of a Traditional Chinese Medicine formulation and the herbal extract, Iberogast, in a rat model of colitis. Poster Presentation, Australian Gastroenterology Week, Gold Coast, Queensland. J Gastro Hepatol 25(3): A82 (2010).

178. RR Nadhanan, MA Scherer, T Shandala, Su Y-W, GS Howarth, SM Abimosleh and CJ Xian. Dietary Emu Oil supplementation may suppress chemotherapy-induced formation of bone-resorptive cells osteoclasts and prevent bone loss. Oral Presentation P16, Australia and New Zealand Bone and Mineral Society.  Adelaide, South Australia (2010).

179. KY Cheah, SEP Bastian and GS Howarth. Dose responsiveness of Grape Seed Extract in a rat model of mucositis. Oral Presentation, Australian Gastroenterology Week, Gold Coast, Queensland. J Gastro Hepatol 25(3): A114 (2010).

180. S Mashtoub Abimosleh, RN Butler and GS Howarth. Effects of Emu oil during the recovery phase of intestinal mucositis in rats. Poster Presentation. Nutrition Society of Australia, Perth, Western Australia (2010).

181. RJ Lindsay, MS Geier, RN Butler and GS Howarth. Effects of prebiotics on metabolism parameters in a rat model of chemotherapy-induced mucositis. Poster Presentation, Australian Gastroenterology Week, Gold Coast, Queensland. J Gastro Hepatol 25(3): A5 (2010).

182. J Woenig, R Donato, P Grover, GS Howarth and AG Cummins. Inhibition of Notch signalling by DAPT decreases postnatal intestinal growth in the rat. Poster Presentation. 5th Australian Health and Medical Research Congress, Melbourne, Victoria (2010).

183. S Mashtoub Abimosleh, CD Tran and GS Howarth. Emu oil promotes repair from chemotherapy-induced intestinal mucositis in rats. Poster Presentation. Australian Gastroenterology Week, Brisbane, Queensland, J Gastro Hepatol 26(4): 15 (2011); and Poster Presentation, Multinational Association of Supportive Care in Cancer (MASCC), Athens, Greece. Supportive Care in Cancer 19 (2):A390 (2011).

184. LD Prisciandaro, MS Geier, RN Butler, AG Cummins and GS Howarth. Pre-treatment with probiotic factors protects intestinal cells from 5-Fluorouracil induced changes in transepithelial resistance and caspase 3/7 activation. Poster Presentation, Multinational Association of Supportive Care in Cancer (MASCC), Athens, Greece Supportive Care in Cancer 19 (2):A151 (2011).

185. CL Brook, R Yazbeck, A Lawrence and GS Howarth. Streptococcus thermophilus TH-4 and effects on Doxorubicin-induced mucositis. Poster Presentation, Digestive Diseases Week, Chicago, USA; and Multinational Association of Supportive Care in Cancer (MASCC), Athens, Greece (2011).

186. RJ Lindsay, MS Geier, RN Butler and GS Howarth. Effects of prebiotics on metabolism parameters in a rat model of chemotherapy-induced mucositis. Poster Presentation. Multinational Association of Supportive Care in Cancer (MASCC), Athens, Greece. Supportive Care in Cancer 19 (2):A387 (2011).

187. J Woenig, P Grover, GS Howarth, IC Roberts-Thompson and AG Cummins. Inhibition of Notch signalling decreases crypt fission but increases apoptosis of crypt cells in the small intestine of the infant rat. Poster Presentation. Digestive Diseases Week, Chicago, USA. Gastroenterology 140(5): S472 (2011).

188. KY Cheah, SEP Bastian and GS Howarth. Grape Seed Extract: a potential adjunct to chemotherapy. Poster Presentation: P19, Australian Society for Medical Research (SA Section) and Oral Presentation. Australian Gastroenterology Week, Brisbane, Queensland. J Gastro Hepatol 26(4): 90 (2011).

189. S Mashtoub Abimosleh, CD Tran and GS Howarth. Emu oil promotes repair from chemotherapy-induced intestinal mucositis in rats. Oral Presentation. Nutrition Society of Australia, Queenstown, New Zealand. Aust Med J. 4(12): 704-716 (2011).

190. EN Schaefer, JO Harris, DAJ Stone and GS Howarth. Histological changes in Haliotis laevigata in response to different dietary protein levels and water temperatures. Oral Presentation. 8th International Abalone Symposium, Hobart, Tasmania (2012).

191. L Wright, REA Forder, GS Howarth and DA Trott. Variable and strain-dependent adhesion of commensal and pathogenic Escherichia coli to the small intestine of low bacterial load and conventionally-reared chicks. Oral Presentation. World’s Poultry Congress, Salvador, Bahia, Brazil (2012).

192. SM Abimosleh, REA Forder, Z Lotfollahi, J Papini, L Hoyle, D Stomaci, E Penascoza, CD Tran, KA Lymn, RN Butler and GS Howarth.. Orally-administered Emu Oil maintains intestinal goblet cell numbers and improves barrier function in a rat model of chemotherapy-induced mucositis. Poster Presentation. World’s Poultry Congress, Salvador, Bahia, Brazil (2012).

193. GS Howarth, RN Butler, S Salminen, GA Gibson and SM Donovan. Probiotics and their derived factors: pre-clinical systems to identify efficacy. Oral Presentation. S247. Experimental Biology 2012, San Diego, California (2012).

194. SM Abimosleh, Z Lotfollahi, J Papini, L Hoyle, D Stomaci, E Penascoza, CD Tran, KA Lymn, RN Butler and GS Howarth.. Orally-administered Emu Oil maintains intestinal goblet cell numbers and improves barrier function in a rat model of chemotherapy-induced mucositis. Poster Presentation P46, Australian Society for Medical Research (SA Section), Adelaide, SA; and Poster Presentation. Multinational Association of Supportive Care in Cancer (MASCC), New York, USA Supp Care Cancer 20(1): 627 (2012).

195. M Bansemer, REA Forder, GS Howarth, JN Bowyer and DA Stone. Effects of solvent extracted soybean meal and water temperature on the intestinal mucus layer and the development of sub-acute enteritis in Yellowtail Kingfish Seriola lalandi. Oral Presentation. Skretting Australasian Aquaculture Conference, Melbourne, Victoria (2012).

196. DA Stone, RP Miegel, SJ Pain and GS Howarth. Water temperature affects gut transit time, digestive enzyme activity and nutrient digestibility in Yellowtail Kingfish Seriola lalandi. Oral Presentation. Skretting Australasian Aquaculture Conference, Melbourne, Victoria (2012).

197. SM Abimosleh, Z Lotfollahi, J Papini, L Hoyle, D Stomaci, E Penascoza, CD Tran, KA Lymn, RN Butler and GS Howarth.. Orally-administered Emu Oil maintains intestinal goblet cell numbers and improves barrier function in a rat model of chemotherapy-induced mucositis. Poster Presentation. Australian Gastroenterology Week, Adelaide, South Australia. J Gastro Hepatol 27(4): 17 (2012).

198. AK Samanta, VA Torok, NJ Percy, SM Abimosleh and GS Howarth. Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis. Australian Gastroenterology Week, Adelaide, South Australia. J Gastro Hepatol 27(4): 28 (2012).

(g) Patent
Granted
Method of preventing or treating alimentary tract damage due to chemotherapy or radiation. Inventors: Leanna C Read and Gordon S Howarth.  Australian Patent No. 689719.  Priority numbers: AU1995PN02712 19950502 (Aust); WO1996AU00253 19960502 (World). Duration: 20 years from May 2nd 1996. Patent granted in Australia, United States, New Zealand, Europe, Canada and Japan. Phase 1b clinical trial completed through Peter MacCallum Cancer Institute, Melbourne, December 2002. Phase IIb commenced October 2006. Prince HM et al. A Phase Ib Clinical Trial of PV701, a Milk-Derived Protein Extract, for the Prevention and Treatment of Oral Mucositis in Patients Undergoing High-Dose BEAM Chemotherapy. Biol Blood Marrow Transplant. 2005 Jul;11(7):512-20. Intellectual Property transferred to TGR BioSciences Pty Ltd in 2005. Nanyang Ventures supported Phase II trial completed February 2008. Marketed as Lactermin. 2009: TGR BioSciences also pursuing options for applications to other markets for specialised aspects of oral care.

Professional Associations

Membership of Scientific Societies

• Endocrine Society of Australia 1995-Present
• Gastroenterological Society of Australia 1993-Present
• Australian Society for Medical Research 1988-Present
• Paediatric Research Society of Australia and New Zealand 1995-Present
• American Gastroenterological Association 1997-Present
• International Society for IGF and Growth Hormone Research 1998-Present
• Coeliac Society of Australia 1992-Present
• Nutrition Society of Australia 2006-Present
• Healthy Development Adelaide 2006-Present

Community Engagement

Professor Howarth is an ambassador for the Cancer Council SA as part of his duties as a CCSA Research Fellow. He was a member of the School of Agriculture, Food and Wine Communication Committee as well as being the Post-Graduate Coordinator and Deputy Head of the Discipline of Agricultural and Animal Science from 2006-2009. He is currently (2010-) Chair of the HDR and Honours Committee for the School of Animal and Veterinary Sciences in addition to being a member of the School Executive, Research Committee, Animal Resource and Reference Committee and the University Institutional Biosafety Committee.

Involvement in the Wider Community
Nov 2012 Mistletoe extract and colon cancer. TV media interviews for ABC, Channel 7, Channel 9 and Channel 10. Printed media including The Advertiser (December 1st), Brisbane Times. Radio interviews including ABC (Sydney) and 5AA. 67,000 Google hits as at December 2012
Nov 2012 Fremont-Elizabeth City High School Awards Night. Award presenter. Shedley Theatre, Playford Civic Centre, Elizabeth, SA
Sept 2012  Lunchtime presentation to senior science students at Fremont-Elizabeth City High School
July 2012  Hosted Healthy Development Adelaide presentation by American Nutrition Society President, Professor Sharon Donovan. State Library of South Australia
July 2012 Hosted Craigmore High School work-experience student, Nikki Lansdowne, for one week
Feb 2012 Launch of cancer theme for South Australian Health & Medical Research Institute, Convention Centre, Adelaide, SA
Nov 2011 Fremont-Elizabeth City High School Awards Night. Award presenter. Shedley Theatre, Playford Civic Centre, Elizabeth, SA
Nov 2011 Hosted Xavier College work-experience student, Laura Skelton, for one week
Oct 2011 Speed networking event at Roseworthy Campus for students of Fremont-Elizabeth City High School and Golden Grove High School
Sept 2011 Commenced mentoring program for students Jane Yang and Trenten Mills at Fremont-Elizabeth City High School
Aug 2011 Presentation on science careers: Invited to open Time Capsule and new Science laboratories at Fremont-Elizabeth City High School
Aug 2011 Finalist: Unsung hero of Science Communication. Science Alive. Presentation Night. Royal Adelaide Showgrounds, Adelaide, SA
Aug 2011 Nutrition research as a career. Healthy Development Adelaide presentation at St Francis de Sales Catholic College, Mount Barker, SA.
Aug 2011 Scientists in Schools presentation on Year 12 secondary school research project initiative. Roseworthy Campus, University of Adelaide
July 2011 National ABC Radio Drive Time Interview: Probiotics
May 2011 Hosted St Michael’s College Year 11 Work Experience student, Shenae Toohey for one week
Apr 2011 Presentation on Cancer Research: 2011 Relay for Life Twilight ceremony. Santos Stadium, 8pm, April 9th 2011
Mar 2011 Careers in Animal Nutrition. Nutrition Society of Australia, University of South Australia, Adelaide
Dec 2010 Cancer Council SA reception. Invited to present at 2011 Relay for Life Twilight ceremony. Santos Stadium, April 2011
Nov 2010 Hosted visiting French Work Experience student, Sophie Scemama de Gialluly for 2 days at Women’s and Children’s Hospital
Nov 2010 Fremont-Elizabeth City High School Awards Night. Keynote Presentation. Shedley Theatre, Playford Civic Centre, Elizabeth, SA
Nov 2010 Playford City Council Networking Breakfast presentation on Year 12 secondary school research project initiative
Oct 2010 Presentation to Health Education Committee, Playford City Council on Year 12 secondary school research project initiative
Sept 2010 ‘Scientific Speed Dating’ and Year 12 secondary school research project initiative presented to Playford City Council
Sept 2010 Presentation to CSIRO Double Helix Club, Education Development Centre, Hindmarsh, SA
Sept 2010 TV Interview. A Current Affair (Sept 13th). ‘Emu Oil: Arthritis Oil’
Sept 2010 Hosted Wilderness College Work Experience Student, Emma Thompson for one week
Sept 2010 Ceremony for presentation of Trevor Prescott Freemason’s Fellowship to PhD student, Suzanne Abimosleh by Adelaide Lord Mayor, Mr Michael Harbison, Adelaide Town Hall
Sept 2010 City of Playford: ‘Playford Pathways’ Year 12 secondary school research project initiative: Twinning with Golden Grove High School
Aug 2010 Multicultural Science event, BioInnovation SA Incubator, Thebarton Biotechnology Precinct, Adelaide, SA
Jul 2010 Presentation to Gleeson College with PhD student, Suzanne Abimosleh
Jun 2010 Hosted Trinity College Work Experience Student, Laura Schloithe for one week
Jun 2010 Presentation at Summit for ‘Relay for Life’ team captains at Cancer Council South Australia, Adelaide, SA
May 2010 ‘Scientists visit Schools’: Roxby Downs Sun (27/5/10) and Roxby Downs Monitor (27/5/10)
May 2010 Presentations (4) to Roxby Downs Area School with PhD students, Suzanne Abimosleh and Ruth Lindsay
Mar 2010 Presentation at Cancer Council South Australia ‘Relay for Life’, Santos Stadium, Adelaide, SA
Jan 2010 Tour Down Under Corporate Cancer Council event (Cancer Council Helpline Classic)
Nov 2009 TV New Zealand. NZ mussel extract can ease chemo effects
Nov 2009 ABC Radio interview, State News, Adelaide, SA
Nov 2009 ABC Radio interview, Afternoons with Carol Whitelock, Adelaide, SA. Syndicated to ABC Broken Hill (Broken Hill), ABC North and West SA (Port Pirie), ABC Riverland SA (Renmark), ABC South East SA (Mt Gambier), ABC West and Coast SA (Port Lincoln)
Nov 2009 Yahoo 7 News Australia. NZ mussel extract may mitigate chemotherapy effects. au.news.yahoo.com.
Nov 2009 Research Tuesday, Public Lecture, Napier Building, University of Adelaide
Nov 2009 Scientists in Schools, Interactive session (1) with Year 10 students from Golden Grove High School, Women’s and Children’s Hospital
Nov 2009 Scientists in Schools, Interactive session (2) with Year 10 students from Golden Grove High School, University of Adelaide (Roseworthy Campus)
Sept 2009 Scientists in Schools, Networking Forum, BioInnovation SA Biotechnology Incubator, Thebarton, South Australia
Sept 2009 Scientific Speed Dating, Interactive Secondary School Event, Innovation House, Mawson Lakes, South Australia
Aug 2009 Presentation to Annesley College, Wayville, Adelaide
July 2009 Hosted work-experience students, Reem Hasseneen and Tammy Howarth (Adelaide University) for one week (July 5-9th)
June 2009 Hosted Seymour College work-experience student, Sarah Hayes for one week (June 22-26th)
May 2009 ABC Radio interview, Afternoons with Carol Whitelock, Adelaide, SA
May 2009 Appointed as judge for Young Investigator Award, Adelaide, SA
May 2009 Young Druze Professionals of South Australia: Official Guest, 14th Annual Graduation Night, Australian Druze Community Hall, Glynde, Adelaide, SA
Mar 2009 Research Update. Hosted presentations to Board of Cancer Council SA (CCSA), by PhD students Luca Prisciandaro, Suzanne Mashtoub and Ruth Lindsay. CCSA Head Office, March 27th, 2009
Feb 2009 Relay for Life. Presentation to Team Captains, Cancer Council SA Head Office, February 16th, 2009
Jan 2009 LIVESTRONG global cancer campaign. Lance Armstrong Foundation Australian launch, Eleanor Harrald Building, Royal Adelaide Hospital
Dec 2008 The Dirty End of Science. Newspaper article. Messenger News Review Wednesday, December 10th Edition
Oct 2008 Playford Pathways Structured Work Placement. City of Playford initiative. Hosted work experience student, Roseanne Bell from Craigmore Christian College
Sept 2008 Student Research Scheme Presentation Night, EDS Centre, Hindmarsh, Adelaide. Received certificate for hosting 6 Year 12 students
Aug 2008 Natural bioactives and prevention of mucositis. TV Interview, Channel 7 News, August 19th. Also appeared on Sky News and CNN
Aug 2008 Presentation to Kildare College, Holden Hill, Adelaide
May 2008 Presentation to Cancer Council Benefactors (Judith Roberts Society), State Library, Adelaide
May 2008 Presentation to St Peter’s Girls Collegiate, St Peters, Adelaide
April 2008 Participated in Playford Pathways Conference – providing career vocation for young people in the Adelaide Electorate of Playford
Feb 2008 Invitation from SA Governor Rear Admiral Kevin Scarce to attend Government House to form the Playford Alumni – a vocational mentoring program for the Adelaide Electorate of Playford
Mar 2007 Radio interview (5UV, March 8th) in relation to marine extract treatment for intestinal mucositis
Mar 2007 Interviewed for Channel 10 TV News segment (March 7th) in relation to marine extract treatment for intestinal mucositis
Feb 2007 Participated in Cancer Council SA sponsored inaugural Walk for Real Hope (Victoria Square to Elder Park, Adelaide, SA)
Nov 2006 Cancer Research. Presentation to Veteran and Vintage Chevrolet Car Club of South Australia
Sept 2006 Cancer Research and the University of Adelaide. Presentation to University of Adelaide Alumni (Roseworthy Campus)
July 2006 Cancer Research and the University of Adelaide. Presentation to CONASTA (Science teachers of Australia annual conference: Waite Institute, University of Adelaide)
Apr 2006 Cancer Research and the Cancer Council SA. Presentation to Adelaide Cancer Council sub-section (International Motel, Glenelg)
Oct 2005 Cancer Research and the Cancer Council SA. Presentation to Legacy Ladies, Salisbury, SA 
Oct 2005 Cancer Research and the Cancer Council SA. Presentation to Port Pirie Cancer Council sub-section (Solomontown Football Club, Port Pirie)
July 2005 Medical Research and You. Presentation to Year 11 students – Salisbury East Secondary School
On-going Work experience coordinator: Women’s and Children’s Hospital
2005-2007 Governing Council, Salisbury East High School. Introduced Vocational Awareness Program (VAP) to educate secondary students in medical research as a possible career
Dec 2004 Twinning Program- Linking Science Teachers with Scientists
Dec 2004 Recruiting senior citizens to perform the sucrose breath test. Salisbury branch of the Returned Servicemen’s League (RSL)
Aug 2004 Research at CHRI/WCH. Christ Baptist Church O’Halloran Hill, SA
Mar 2004 Coordinator of Women’s and Children’s Hospital Research Education Workshop for Senior Secondary students
Mar 2003 Medical Research at CHRI. General Motors Day, Tanunda, Barossa Valley, South Australia 
1994-2003 Governing Council: Salisbury Park Primary School, Chairperson 1999-2003. Involved in Vocational Awareness Program (VAP) to educate   upper-primary school children in medical research as a possible career
Dec 2002 Medical Research at CHRI. Venuto Italian Club, Adelaide, SA
Oct 2002 Whey growth factors and intestinal disease. Radio interviews (Local, rural, Adelaide stations plus South Africa, Brisbane, regional stations)
Aug 2002 Bowel Research at CHRI. Veteran and Vintage Chevrolet Car Club of South Australia
July 2002 Medical Research at CHRI. Christ Baptist Church (O’Halloran Hill, Adelaide, SA) 
Sept 1996 Medical Research and the Women’s and Children’s Hospital. Presentation to Salisbury Park Primary School
July 1996 Research at CHRI.  Xmas in Winter Fund-raising event
June 1996 Research at CHRI.  Gawler Jaycees Fund-raising event
May 1996 Host – School Career Day, Women’s and Children’s Hospital, Adelaide
Mar 1995 Research at CHRI and Coeliac Disease. Coeliac Society Information Night, Women’s and Children’s Hospital, Adelaide
July 1992-2002 Research into IBD. Crohn’s and Colitis Association of SA. Annual presentation to Association each July until Association closed in 2002
1992-2004 Work experience coordinator at CHRI. Hosted more than 30 secondary (Year 10 to Year 12) and tertiary students and have employed several    former  students (eg Carolyn Mardell, Research Assistant 1992-2000),   Ben Edwards (Technical Officer 1996-2000), Lynn Scarman (Manager   WCH Animal Care 1999), Martina Erhlers (Research Assistant: 2004)
1995-2000 Co-hosted visits to CHRI by politicians, local investors, entertainers and other dignitaries including Ms Jeanette Howard (wife of Prime    Minister-2000) and Senator Chris Schatt (1995)
Feb 1993-1995 Glendi Festival (annual display) – promoting Women’s and Children’s Hospital Gastroenterology Department
Apr 1992-1995 Mothers and Babies Expo (annual display) – promoting CHRI

Expertise for Media Contact

Categories	Animals and veterinary science, Medicine and medical research
Expertise	Animal models;gastrointestinal disease;bioactives;nutraceuticals;plant extracts;animal oils;probiotics;prebiotics;synbiotics;digestive health
Notes	Admitted to Royal College of Pathologists of Australasia 2004. Awarded Cancer Council SA Fellowship 2005. Admitted as inaugural Fellow of the American Gastroenterological Association 2006. Awarded nationally-competitive Sally birch cancer Council Australia Senior Research Fellowship in Cancer Control 2009-2011.

Entry last updated: Thursday, 17 Jan 2013